<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell. Infect. Microbiol.</journal-id>
<journal-title>Frontiers in Cellular and Infection Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell. Infect. Microbiol.</abbrev-journal-title>
<issn pub-type="epub">2235-2988</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fcimb.2024.1347110</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cellular and Infection Microbiology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Bibliometric analysis of intestinal microbiota and lung diseases</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Sun</surname>
<given-names>Weiting</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2024796"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Zhou</surname>
<given-names>Tong</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2404328"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ding</surname>
<given-names>Peng</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1724082"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Guo</surname>
<given-names>Liuxue</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2169734"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Zhou</surname>
<given-names>Xiujuan</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Long</surname>
<given-names>Kunlan</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Critical Care Medicine, Hospital of Chengdu University of Traditional Chinese Medicine</institution>, <addr-line>Chengdu</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>School of Clinical Medicine, Chengdu University of Traditional Chinese Medicine</institution>, <addr-line>Chengdu</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Valeriy Poroyko, Laboratory Corporation of America Holdings (LabCorp), United States</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Weiming Sun, First Affiliated Hospital of Nanchang University, China</p>
<p>M Ahmed, Phcog.Net, India</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Xiujuan Zhou, <email xlink:href="mailto:zhouxiujuan@cdutcm.edu.cn">zhouxiujuan@cdutcm.edu.cn</email>; Kunlan Long, <email xlink:href="mailto:191430865@qq.com">191430865@qq.com</email>
</p>
</fn>
<fn fn-type="equal" id="fn003">
<p>&#x2020;These authors have contributed equally to this work</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>15</day>
<month>02</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>14</volume>
<elocation-id>1347110</elocation-id>
<history>
<date date-type="received">
<day>30</day>
<month>11</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>09</day>
<month>01</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2024 Sun, Zhou, Ding, Guo, Zhou and Long</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Sun, Zhou, Ding, Guo, Zhou and Long</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Background</title>
<p>Increasing evidence suggests a close association between the intestinal microbiome and the respiratory system, drawing attention to studying the gut-lung axis. This research employs bibliometric methods to conduct a visual analysis of literature in the field of intestinal microbiota and lung diseases over the past two decades. It offers scientific foundations for research directions and critical issues in this field.</p>
</sec>
<sec>
<title>Methods</title>
<p>We retrieved all articles on intestinal microbiota and lung diseases from the SCI-Expanded of WoSCC on October 25, 2023. The analysis included original articles and reviews published in English from 2011 to 2023. We utilized Python, VOSviewer, and CiteSpace to analyze the retrieved data visually.</p>
</sec>
<sec>
<title>Results</title>
<p>A total of 794 publications were analyzed. China ranked first in the number of publications, while the United States had the highest citations and H-index. Jian Wang was the most prolific author. Zhejiang University was the institution with the highest number of publications. <italic>Frontiers in Microbiology</italic> was the journal with the most publications. Author keywords appearing more than 100 times included &#x201c;intestinal microbiota/microbiome&#x201d;, &#x201c;microbiota/microbiome&#x201d;, and &#x201c;gut-lung axis&#x201d;.</p>
</sec>
<sec>
<title>Conclusion</title>
<p>The correlation and underlying mechanisms between intestinal microbiota and lung diseases, including asthma, COPD, lung cancer, and respiratory infections, remain hot topics in research. However, understanding the mechanisms involving the gut-lung axis is still in its infancy and requires further elucidation.</p>
</sec>
</abstract>
<kwd-group>
<kwd>intestinal microbiota</kwd>
<kwd>lung</kwd>
<kwd>bibliometric analysis</kwd>
<kwd>VOSviewer</kwd>
<kwd>Citespace</kwd>
</kwd-group>
<counts>
<fig-count count="12"/>
<table-count count="6"/>
<equation-count count="0"/>
<ref-count count="86"/>
<page-count count="17"/>
<word-count count="5830"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Intestinal Microbiome</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<label>1</label>
<title>Introduction</title>
<p>The intestinal microbiota refers to the microbial ecosystem within the human gastrointestinal tract, encompassing bacteria, fungi, viruses, and other microorganisms. The gene pool of this microbiota exceeds that of the human genome by a hundredfold (<xref ref-type="bibr" rid="B50">O&#x2019;Hara and Shanahan, 2006</xref>; <xref ref-type="bibr" rid="B27">Grice and Segre, 2012</xref>; <xref ref-type="bibr" rid="B36">Ley et&#xa0;al., 2006</xref>). Changes in the composition and diversity of these microorganisms can impact not only the colonized organ but also distant organs and systems (<xref ref-type="bibr" rid="B20">Feng et&#xa0;al., 2018</xref>). The intestinal microbiota is closely linked to human health and is associated with various diseases, such as gastrointestinal disorders, metabolic diseases, and immune-related illnesses (<xref ref-type="bibr" rid="B86">Zhou et&#xa0;al., 2021</xref>; <xref ref-type="bibr" rid="B17">de Steenhuijsen Piters et&#xa0;al., 2015</xref>; <xref ref-type="bibr" rid="B14">Clemente et&#xa0;al., 2012</xref>). Current research indicates that dysbiosis of the intestinal microbiota is a fundamental cause of numerous gastrointestinal and non-gastrointestinal diseases and a range of mental health conditions (<xref ref-type="bibr" rid="B10">Carding et&#xa0;al., 2015</xref>; <xref ref-type="bibr" rid="B22">Forsythe et&#xa0;al., 2016</xref>). Recent evidence suggests intestinal microbiota is intricately connected to the respiratory system, acting as a critical regulatory factor in developing lung diseases like pneumonia, asthma, and chronic obstructive pulmonary disease (COPD) (<xref ref-type="bibr" rid="B75">Wang et&#xa0;al., 2017</xref>). While research on the gut-lung axis is still in its early stages, it holds potential as a novel approach for treating pulmonary diseases (<xref ref-type="bibr" rid="B20">Feng et&#xa0;al., 2018</xref>).</p>
<p>Bibliometrics is a quantitative research method used to analyze and assess scientific literature&#x2019;s volume, quality, distribution, and impact. It involves statistical analysis of citations, author collaborations, and journal impact factors (<xref ref-type="bibr" rid="B43">Ma et&#xa0;al., 2021</xref>). Employing bibliometric methods can reveal the latest scientific research trends, hot topics, and interdisciplinary fields, as well as evaluate the impact and quality of academic achievements, providing decision support for the advancement of scientific research (<xref ref-type="bibr" rid="B28">Guler et&#xa0;al., 2016</xref>). No study has systematically explored the interrelationship between intestinal microbiota and lung diseases using bibliometric methods. This study aims to employ bibliometric techniques to quantitatively analyze research on the intestinal microbiota and the lung, providing a scientific basis for research directions and significant issues in this field.</p>
</sec>
<sec id="s2" sec-type="materials|methods">
<label>2</label>
<title>Materials and methods</title>
<sec id="s2_1">
<label>2.1</label>
<title>Data source and retrieval</title>
<p>We systematically searched the WoSCC database, setting the search timeframe from the database&#x2019;s inception to 2023, with the search completed on October 25, 2023. A total of 1364 articles were retrieved, and the selection process was finalized on October 27, 2023. The search strategy was as follows:</p>
<list list-type="simple">
<list-item>
<p>1: [TI=(&#x201c;gut microbiota&#x201d; OR &#x201c;intestinal microbiota&#x201d; OR &#x201c;fecal microbiota&#x201d; OR &#x201c;gastrointestinal microbiota&#x201d; OR &#x201c;gut microbiome&#x201d; OR &#x201c;intestinal microbiome&#x201d; OR &#x201c;fecal microbiome&#x201d; OR &#x201c;gastrointestinal microbiome&#x201d; OR &#x201c;intestinal bacteria&#x201d; OR &#x201c;gut bacteria&#x201d; OR &#x201c;fecal bacteria&#x201d; OR &#x201c;gastrointestinal bacteria&#x201d; OR &#x201c;intestinal flora&#x201d; OR &#x201c;gut flora&#x201d; OR &#x201c;fecal flora&#x201d; OR &#x201c;gastrointestinal flora&#x201d; OR &#x201c;gut microflora&#x201d; OR &#x201c;intestinal microflora&#x201d; OR &#x201c;fecal microflora&#x201d; OR &#x201c;gastrointestinal microflora&#x201d;)] OR AB=(&#x201c;gut microbiota&#x201d; OR &#x201c;intestinal microbiota&#x201d; OR &#x201c;fecal microbiota&#x201d; OR &#x201c;gastrointestinal microbiota&#x201d; OR &#x201c;gut microbiome&#x201d; OR &#x201c;intestinal microbiome&#x201d; OR &#x201c;fecal microbiome&#x201d; OR &#x201c;gastrointestinal microbiome&#x201d; OR &#x201c;intestinal bacteria&#x201d; OR &#x201c;gut bacteria&#x201d; OR &#x201c;fecal bacteria&#x201d; OR &#x201c;gastrointestinal bacteria&#x201d; OR &#x201c;intestinal flora&#x201d; OR &#x201c;gut flora&#x201d; OR &#x201c;fecal flora&#x201d; OR &#x201c;gastrointestinal flora&#x201d; OR &#x201c;gut microflora&#x201d; OR &#x201c;intestinal microflora&#x201d; OR &#x201c;fecal microflora&#x201d; OR &#x201c;gastrointestinal microflora&#x201d;)</p>
</list-item>
<list-item>
<p>2: [TI=(&#x201c;pulmonary&#x201d; OR &#x201c;lung&#x201d;)] OR AB=(&#x201c;pulmonary&#x201d; OR &#x201c;lung&#x201d;)</p>
</list-item>
<list-item>
<p>3: #1 AND #2</p>
</list-item>
</list>
<p>Two reviewers independently identified and discussed potential discrepancies in the data search, ultimately reaching a consensus. After excluding articles written in non-English and those whose titles and abstracts did not match the research content, and by restricting the publication type to reviews and original articles, we obtained 794 articles that met the criteria for inclusion in the analysis (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref>).</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Flowchart of literature search selection.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-14-1347110-g001.tif"/>
</fig>
<p>This approach ensured a comprehensive and focused collection of relevant literature, providing a robust foundation for the subsequent bibliometric analysis.</p>
</sec>
<sec id="s2_2">
<label>2.2</label>
<title>Data collection</title>
<p>The original data were extracted from WoSCC database, including paper and citation numbers, publication year, country/region, affiliation, authors, journals, references, and keywords. The data were imported into VOSviewer (version 1.6.19) and CiteSpace (version 6.2.R3) for subsequent bibliometric analysis.</p>
<p>The Web of Science (WoS) Core Collection database, known for its rigorous journal selection, has become internationally recognized for evaluating the scientific achievements of scholars and institutions and for assessing the development of disciplines (<xref ref-type="bibr" rid="B65">Sun et&#xa0;al., 2022</xref>). Therefore, our research chose the WoS database.</p>
<p>CiteSpace is a software tool for visualizing and analyzing academic literature citation networks. It automatically generates citation network graphs and calculates citation frequency, keyword distribution, collaboration among authors, and displays this information in visual charts. CiteSpace also offers a range of analysis tools, such as clustering analysis and keyword co-occurrence analysis, to help researchers identify important research themes, hotspots, and influential papers in academic fields (<xref ref-type="bibr" rid="B66">Synnestvedt et&#xa0;al., 2005</xref>).</p>
<p>Similar to CiteSpace, VOSviewer supports visualization analysis based on literature citation networks. Using VOSviewer, researchers can easily explore citation relationships between literature and research hotspots. It aids in quickly grasping an overview of large-scale literature data, assisting in identifying field hotspots, research trends, and relevant literature resources and research directions related to specific research questions (<xref ref-type="bibr" rid="B73">van Eck and Waltman, 2010</xref>; <xref ref-type="bibr" rid="B51">Pan et&#xa0;al., 2018</xref>). In the generated network graphs, nodes can represent different countries, institutions, authors, or keywords. The size of a node reflects the number of publications associated with it, while different colors represent different clusters or years. Lines between nodes reveal collaboration or citation relationships.</p>
<p>Python is an open-source programming language known for its flexibility and productivity. Compared to traditional data visualization tools, Python offers the availability of multiple plotting and graphics libraries and the customization of various types of advanced charts (<xref ref-type="bibr" rid="B76">Wang and Maniruzzaman, 2022</xref>). Our study utilized Python to extract multiple key attributes from the literature, such as publication year, authors, institutions, countries, research fields, journals, references, and author keywords, followed by comprehensive statistical analysis. To visually represent the data, we also created bubble charts illustrating the annual publication trends in various research fields, journals, and author keywords. In these charts, the diameter of a bubble symbolizes the most prominent research field, journal, or author keyword in a particular year, and the number inside the bubble indicates the corresponding number of publications (<xref ref-type="bibr" rid="B65">Sun et&#xa0;al., 2022</xref>).</p>
</sec>
<sec id="s2_3">
<label>2.3</label>
<title>Data cleaning</title>
<p>Before initiating the bibliometric analysis, we meticulously processed the raw data using Python. Our data cleaning process involved several key steps:</p>
<list list-type="alpha-lower">
<list-item>
<p>Country Consolidation: We merged countries that are geographically or politically part of the same entity. For example, Scotland, England, and Northern Ireland were combined under &#x201c;United Kingdom&#x201d;.</p>
</list-item>
<list-item>
<p>Synonym Merging for Countries: We consolidated synonyms for countries, such as replacing &#x201c;Peoples R China&#x201d; and &#x201c;Taiwan&#x201d; with &#x201c;China&#x201d;.</p>
</list-item>
<list-item>
<p>Standardization of Country Abbreviations: We standardized country abbreviations, for instance, converting &#x201c;USA&#x201d; to &#x201c;United States&#x201d;.</p>
</list-item>
<list-item>
<p>Keyword Standardization: To avoid loss of information due to synonyms among keywords, we deduced author keywords and replaced synonyms with standardized terms.</p>
</list-item>
<list-item>
<p>Author Identity Verification: We conducted thorough identity verification to eliminate confusion caused by authors with the same name. Besides using ORCID information for identity verification, we also referred to reliable sources such as official institutional websites.</p>
</list-item>
</list>
<p>These steps ensured the accuracy and consistency of our data, which is crucial for the integrity and reliability of our bibliometric analysis.</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<label>3</label>
<title>Results</title>
<sec id="s3_1">
<label>3.1</label>
<title>The annual trend of paper publication quantity</title>
<p>
<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2</bold>
</xref> illustrates the trends in annual publication volume and citation frequency. The total number of articles surged from 3 in 2011 to 190 in 2022. Since 2011, lung and intestinal microbiota research has shown an upward trend. The annual publication volume exceeded 150 articles starting in 2021, indicating a continuous increase in the number of scholars conducting related research and a flourishing development of theories in lung and intestinal microbiota research.</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>Trends in the growth of publications and the number of citations in intestinal microbiota and lung disease.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-14-1347110-g002.tif"/>
</fig>
</sec>
<sec id="s3_2">
<label>3.2</label>
<title>Analysis of authors</title>
<p>Since the database&#x2019;s inception, 5,710 authors have participated in lung and intestinal microbiota research, publishing a total of 794 articles. <xref ref-type="table" rid="T1">
<bold>Table&#xa0;1</bold>
</xref> displays the top 10 core authors, their publication count, total citations, and H-index. The top 10 authors published 63 articles collectively, totalling 1,750 citations. In terms of publication count, Jian Wang leads with 8 publications, followed by Derrick R Samuelson with 7 publications. Among them, 4,963 authors have published only one article, and only 23 have published five or more. Regarding total citations, Benjamin J Marsland leads with 2,522 citations, though outside the top 10 authors. Eva S Gollwitzer followed them with 2,120 citations and Aurelien Trompette with 2,052 citations. Regarding H-index, Valentin Sencio and Francois Trottein are in the leading positions. When assessing prolific authors, it is essential to consider the quantity of articles and the quality and publication timeline.</p>
<table-wrap id="T1" position="float">
<label>Table&#xa0;1</label>
<caption>
<p>Contribution of the top 10 authors in intestinal microbiota and lung diseases.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="left">Rank</th>
<th valign="top" align="left">Author</th>
<th valign="top" align="left">Institution</th>
<th valign="top" align="left">Country</th>
<th valign="top" align="left">Publications</th>
<th valign="top" align="left">Citations</th>
<th valign="top" align="left">H-index</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="right">1</td>
<td valign="top" align="left">Wang, Jian</td>
<td valign="top" align="left">Univ Sci &amp; Technol China</td>
<td valign="top" align="left">China</td>
<td valign="top" align="right">8</td>
<td valign="top" align="right">350</td>
<td valign="top" align="right">3</td>
</tr>
<tr>
<td valign="top" align="right">2</td>
<td valign="top" align="left">Samuelson, Derrick R.</td>
<td valign="top" align="left">Louisiana State Univ</td>
<td valign="top" align="left">United States</td>
<td valign="top" align="right">7</td>
<td valign="top" align="right">319</td>
<td valign="top" align="right">5</td>
</tr>
<tr>
<td valign="top" align="right">3</td>
<td valign="top" align="left">Sencio, Valentin</td>
<td valign="top" align="left">Univ Lille</td>
<td valign="top" align="left">France</td>
<td valign="top" align="right">6</td>
<td valign="top" align="right">398</td>
<td valign="top" align="right">6</td>
</tr>
<tr>
<td valign="top" align="right">3</td>
<td valign="top" align="left">Trottein, Francois</td>
<td valign="top" align="left">Univ Lille</td>
<td valign="top" align="left">France</td>
<td valign="top" align="right">6</td>
<td valign="top" align="right">398</td>
<td valign="top" align="right">6</td>
</tr>
<tr>
<td valign="top" align="right">3</td>
<td valign="top" align="left">Li, Jing</td>
<td valign="top" align="left">Univ FloridaUnited States</td>
<td valign="top" align="left">
</td>
<td valign="top" align="right">6</td>
<td valign="top" align="right">134</td>
<td valign="top" align="right">3</td>
</tr>
<tr>
<td valign="top" align="right">3</td>
<td valign="top" align="left">Zhang, Jun</td>
<td valign="top" align="left">Univ Iowa Hosp &amp; Clin</td>
<td valign="top" align="left">United States</td>
<td valign="top" align="right">6</td>
<td valign="top" align="right">41</td>
<td valign="top" align="right">3</td>
</tr>
<tr>
<td valign="top" align="right">3</td>
<td valign="top" align="left">Li, Yalan</td>
<td valign="top" align="left">Univ Iowa Hosp &amp; Clin</td>
<td valign="top" align="left">China</td>
<td valign="top" align="right">6</td>
<td valign="top" align="right">33</td>
<td valign="top" align="right">4</td>
</tr>
<tr>
<td valign="top" align="right">3</td>
<td valign="top" align="left">Peng, Guiying</td>
<td valign="top" align="left">Univ Iowa Hosp &amp; Clin</td>
<td valign="top" align="left">China</td>
<td valign="top" align="right">6</td>
<td valign="top" align="right">33</td>
<td valign="top" align="right">4</td>
</tr>
<tr>
<td valign="top" align="right">3</td>
<td valign="top" align="left">Li, Na</td>
<td valign="top" align="left">Univ Iowa Hosp &amp; Clin</td>
<td valign="top" align="left">China</td>
<td valign="top" align="right">6</td>
<td valign="top" align="right">29</td>
<td valign="top" align="right">3</td>
</tr>
<tr>
<td valign="top" align="right">3</td>
<td valign="top" align="left">Liu, Yang</td>
<td valign="top" align="left">Yunnan Univ Tradit Chinese Med</td>
<td valign="top" align="left">China</td>
<td valign="top" align="right">6</td>
<td valign="top" align="right">15</td>
<td valign="top" align="right">2</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>Among the top 10 authors in terms of publication volume, 5 are based in China, 3 in the United States, and 2 in France. This data indicates the concentration of research in this field in specific countries. VOSviewer software was used to depict the collaborations among authors in this field (<xref ref-type="fig" rid="f3">
<bold>Figures&#xa0;3</bold>
</xref>, <xref ref-type="fig" rid="f4">
<bold>4</bold>
</xref>). We set a threshold in the statistical analysis, requiring authors to have published at least 2 articles; ultimately, only 720 authors met this threshold. After removing unconnected nodes, 89 authors met the threshold. In the network visualization, the size of a node increases with the number of contributions by the author. The larger the node, the more articles the author has published.</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>Cooperation map of top 20 authors in intestinal microbiota and lung diseases.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-14-1347110-g003.tif"/>
</fig>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>Cooperation map of authors in intestinal microbiota and lung diseases.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-14-1347110-g004.tif"/>
</fig>
</sec>
<sec id="s3_3">
<label>3.3</label>
<title>Analysis of institutions</title>
<p>1,431 institutions systematically published articles on the lung and intestinal microbiota. The majority of the top 10 institutions in terms of publication volume are from China. Zhejiang University in China ranks first in the number of publications and the H-index, with 26 publications, 878 total citations, and an H-index of 14. Fudan University is second with 18 publications, 297 total citations, and an H-index 8. Shanghai Jiao Tong University (17 publications, 470 total citations) and Sun Yat-sen University (17 publications, 310 total citations) are tied for third place (<xref ref-type="table" rid="T2">
<bold>Table&#xa0;2</bold>
</xref>).</p>
<table-wrap id="T2" position="float">
<label>Table&#xa0;2</label>
<caption>
<p>Contribution of the top 10 institutions in intestinal microbiota and lung diseases.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="bottom" align="center">Rank</th>
<th valign="bottom" align="center">Institution</th>
<th valign="bottom" align="center">Publications</th>
<th valign="bottom" align="center">Citations</th>
<th valign="bottom" align="center">H-index</th>
<th valign="bottom" align="center">Country</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="bottom" align="center">1</td>
<td valign="bottom" align="center">Zhejiang Univ</td>
<td valign="bottom" align="center">26</td>
<td valign="bottom" align="center">878</td>
<td valign="bottom" align="center">14</td>
<td valign="bottom" align="center">China</td>
</tr>
<tr>
<td valign="bottom" align="center">2</td>
<td valign="bottom" align="center">Fudan Univ</td>
<td valign="bottom" align="center">18</td>
<td valign="bottom" align="center">297</td>
<td valign="bottom" align="center">8</td>
<td valign="bottom" align="center">China</td>
</tr>
<tr>
<td valign="bottom" align="center">3</td>
<td valign="bottom" align="center">Shanghai Jiao Tong Univ</td>
<td valign="bottom" align="center">17</td>
<td valign="bottom" align="center">470</td>
<td valign="bottom" align="center">8</td>
<td valign="bottom" align="center">China</td>
</tr>
<tr>
<td valign="bottom" align="center">3</td>
<td valign="bottom" align="center">Sun Yat Sen Univ</td>
<td valign="bottom" align="center">17</td>
<td valign="bottom" align="center">310</td>
<td valign="bottom" align="center">7</td>
<td valign="bottom" align="center">China</td>
</tr>
<tr>
<td valign="bottom" align="center">4</td>
<td valign="bottom" align="center">Capital Med Univ</td>
<td valign="bottom" align="center">16</td>
<td valign="bottom" align="center">282</td>
<td valign="bottom" align="center">7</td>
<td valign="bottom" align="center">China</td>
</tr>
<tr>
<td valign="bottom" align="center">5</td>
<td valign="bottom" align="center">Beijing Univ Chinese Med</td>
<td valign="bottom" align="center">14</td>
<td valign="bottom" align="center">78</td>
<td valign="bottom" align="center">5</td>
<td valign="bottom" align="center">China</td>
</tr>
<tr>
<td valign="bottom" align="center">6</td>
<td valign="bottom" align="center">Univ Paris Saclay</td>
<td valign="bottom" align="center">13</td>
<td valign="bottom" align="center">804</td>
<td valign="bottom" align="center">9</td>
<td valign="bottom" align="center">France</td>
</tr>
<tr>
<td valign="bottom" align="center">6</td>
<td valign="bottom" align="center">Chinese Acad Sci</td>
<td valign="bottom" align="center">13</td>
<td valign="bottom" align="center">354</td>
<td valign="bottom" align="center">5</td>
<td valign="bottom" align="center">China</td>
</tr>
<tr>
<td valign="bottom" align="center">6</td>
<td valign="bottom" align="center">Guangzhou Med Univ</td>
<td valign="bottom" align="center">13</td>
<td valign="bottom" align="center">278</td>
<td valign="bottom" align="center">5</td>
<td valign="bottom" align="center">China</td>
</tr>
<tr>
<td valign="bottom" align="center">6</td>
<td valign="bottom" align="center">Cent South Univ</td>
<td valign="bottom" align="center">13</td>
<td valign="bottom" align="center">169</td>
<td valign="bottom" align="center">7</td>
<td valign="bottom" align="center">China</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>Institutional collaboration analysis was conducted using VOSviewer software, and an institutional collaboration network map was constructed (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5</bold>
</xref>). The minimum publication threshold was set to 5, with 66 institutions meeting this threshold. After removing unconnected nodes, 61 institutions met the criteria. As shown in <xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5</bold>
</xref>, there is close collaboration among these institutions.</p>
<fig id="f5" position="float">
<label>Figure&#xa0;5</label>
<caption>
<p>Cooperation map of institutions in intestinal microbiota and lung diseases.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-14-1347110-g005.tif"/>
</fig>
</sec>
<sec id="s3_4">
<label>3.4</label>
<title>Analysis of countries/regions</title>
<p>Our analysis included 57 countries. The top 10 countries/regions were ranked based on the total number of publications by all authors. China had the highest publication volume, accounting for 45.2%, followed by the United States (21.8%) and France (5.3%) (<xref ref-type="table" rid="T3">
<bold>Table&#xa0;3</bold>
</xref>, <xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6</bold>
</xref>). Only China and the United States published more than 100 articles. Although China had the highest number of publications, the United States led in total citations and H-index, indicating a higher quality of articles. The United States maintained the most vital international collaboration partnerships with other countries in this field.</p>
<table-wrap id="T3" position="float">
<label>Table&#xa0;3</label>
<caption>
<p>Contribution of the top 10 countries/regions in intestinal microbiota and lung diseases.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="left">Rank</th>
<th valign="top" align="left">Country</th>
<th valign="top" align="left">Publications</th>
<th valign="top" align="left">Citations</th>
<th valign="top" align="left">H-index</th>
<th valign="top" align="left">Average <break/>Citations per Publication</th>
<th valign="top" align="left">Number of Cooperative Countries</th>
<th valign="top" align="left">Multinational Publications</th>
<th valign="top" align="left">Share of <break/>multinational cooperation publications</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="bottom" align="right">1</td>
<td valign="bottom" align="left">China</td>
<td valign="bottom" align="right">359</td>
<td valign="bottom" align="right">5411</td>
<td valign="bottom" align="right">36</td>
<td valign="bottom" align="right">15.07</td>
<td valign="bottom" align="right">21</td>
<td valign="bottom" align="right">40</td>
<td valign="bottom" align="right">11.14</td>
</tr>
<tr>
<td valign="bottom" align="right">2</td>
<td valign="bottom" align="left">United States</td>
<td valign="bottom" align="right">173</td>
<td valign="bottom" align="right">5604</td>
<td valign="bottom" align="right">41</td>
<td valign="bottom" align="right">32.39</td>
<td valign="bottom" align="right">33</td>
<td valign="bottom" align="right">77</td>
<td valign="bottom" align="right">44.51</td>
</tr>
<tr>
<td valign="bottom" align="right">3</td>
<td valign="bottom" align="left">France</td>
<td valign="bottom" align="right">42</td>
<td valign="bottom" align="right">2068</td>
<td valign="bottom" align="right">22</td>
<td valign="bottom" align="right">49.24</td>
<td valign="bottom" align="right">21</td>
<td valign="bottom" align="right">18</td>
<td valign="bottom" align="right">42.86</td>
</tr>
<tr>
<td valign="bottom" align="right">4</td>
<td valign="bottom" align="left">Japan</td>
<td valign="bottom" align="right">39</td>
<td valign="bottom" align="right">1188</td>
<td valign="bottom" align="right">17</td>
<td valign="bottom" align="right">30.46</td>
<td valign="bottom" align="right">6</td>
<td valign="bottom" align="right">15</td>
<td valign="bottom" align="right">38.46</td>
</tr>
<tr>
<td valign="bottom" align="right">5</td>
<td valign="bottom" align="left">United Kingdom</td>
<td valign="bottom" align="right">37</td>
<td valign="bottom" align="right">1408</td>
<td valign="bottom" align="right">18</td>
<td valign="bottom" align="right">38.05</td>
<td valign="bottom" align="right">23</td>
<td valign="bottom" align="right">25</td>
<td valign="bottom" align="right">67.57</td>
</tr>
<tr>
<td valign="bottom" align="right">6</td>
<td valign="bottom" align="left">Italy</td>
<td valign="bottom" align="right">35</td>
<td valign="bottom" align="right">923</td>
<td valign="bottom" align="right">15</td>
<td valign="bottom" align="right">26.37</td>
<td valign="bottom" align="right">18</td>
<td valign="bottom" align="right">17</td>
<td valign="bottom" align="right">48.57</td>
</tr>
<tr>
<td valign="bottom" align="right">7</td>
<td valign="bottom" align="left">Australia</td>
<td valign="bottom" align="right">33</td>
<td valign="bottom" align="right">2643</td>
<td valign="bottom" align="right">17</td>
<td valign="bottom" align="right">80.09</td>
<td valign="bottom" align="right">17</td>
<td valign="bottom" align="right">16</td>
<td valign="bottom" align="right">48.48</td>
</tr>
<tr>
<td valign="bottom" align="right">7</td>
<td valign="bottom" align="left">Germany</td>
<td valign="bottom" align="right">33</td>
<td valign="bottom" align="right">1278</td>
<td valign="bottom" align="right">15</td>
<td valign="bottom" align="right">38.73</td>
<td valign="bottom" align="right">14</td>
<td valign="bottom" align="right">18</td>
<td valign="bottom" align="right">54.55</td>
</tr>
<tr>
<td valign="bottom" align="right">8</td>
<td valign="bottom" align="left">Canada</td>
<td valign="bottom" align="right">27</td>
<td valign="bottom" align="right">1510</td>
<td valign="bottom" align="right">20</td>
<td valign="bottom" align="right">55.93</td>
<td valign="bottom" align="right">11</td>
<td valign="bottom" align="right">16</td>
<td valign="bottom" align="right">59.26</td>
</tr>
<tr>
<td valign="bottom" align="right">9</td>
<td valign="bottom" align="left">Netherlands</td>
<td valign="bottom" align="right">23</td>
<td valign="bottom" align="right">1019</td>
<td valign="bottom" align="right">13</td>
<td valign="bottom" align="right">44.3</td>
<td valign="bottom" align="right">15</td>
<td valign="bottom" align="right">18</td>
<td valign="bottom" align="right">78.26</td>
</tr>
</tbody>
</table>
</table-wrap>
<fig id="f6" position="float">
<label>Figure&#xa0;6</label>
<caption>
<p>Cooperation map of countries/regions in intestinal microbiota and lung diseases.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-14-1347110-g006.tif"/>
</fig>
</sec>
<sec id="s3_5">
<label>3.5</label>
<title>Analysis of journals</title>
<p>794 articles related to the lung and intestinal microbiota were published across 333 journals, as detailed in <xref ref-type="table" rid="T4">
<bold>Table&#xa0;4</bold>
</xref>. The journal with the most publications was <italic>Frontiers in Microbiology</italic> (39 articles, accounting for 4.9%), followed by <italic>Frontiers in Immunology</italic> (35 articles, 4.4%), <italic>Frontiers in Cellular and Infection Microbiology</italic> (23 articles, 2.9%), <italic>Plos One</italic> (21 articles, 2.6%), <italic>Nutrients</italic> (17 articles, 2.1%), <italic>Biomedicine &amp; Pharmacotherapy</italic> (16 articles, 2.0%), <italic>Scientific Reports</italic> (15 articles, 1.9%), <italic>International Journal of Molecular Sciences</italic> (15 articles, 1.9%), <italic>Gut Microbes</italic> (13 articles, 1.6%), and <italic>Frontiers in Pharmacology</italic> (12 articles, 1.5%). <italic>Nature Medicine</italic> had the highest total citations (2004) but only published 3 articles.</p>
<table-wrap id="T4" position="float">
<label>Table&#xa0;4</label>
<caption>
<p>Contribution of the top 10 journals in intestinal microbiota and lung diseases.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="center">Rank</th>
<th valign="top" align="center">Journal</th>
<th valign="top" align="center">Publications</th>
<th valign="top" align="center">Citations</th>
<th valign="bottom" align="center">Average <break/>Citations per Publication</th>
<th valign="top" align="center">The percentage of articles of institutions in total publications</th>
<th valign="top" align="center">IF</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="bottom" align="center">1</td>
<td valign="bottom" align="center">FRONTIERS IN MICROBIOLOGY</td>
<td valign="bottom" align="center">39</td>
<td valign="bottom" align="center">1168</td>
<td valign="bottom" align="center">29.95</td>
<td valign="bottom" align="center">4.01</td>
<td valign="bottom" align="center">5.2</td>
</tr>
<tr>
<td valign="bottom" align="center">2</td>
<td valign="bottom" align="center">FRONTIERS IN IMMUNOLOGY</td>
<td valign="bottom" align="center">35</td>
<td valign="bottom" align="center">943</td>
<td valign="bottom" align="center">26.94</td>
<td valign="bottom" align="center">3.6</td>
<td valign="bottom" align="center">7.3</td>
</tr>
<tr>
<td valign="bottom" align="center">3</td>
<td valign="bottom" align="center">FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY</td>
<td valign="bottom" align="center">23</td>
<td valign="bottom" align="center">546</td>
<td valign="bottom" align="center">23.74</td>
<td valign="bottom" align="center">2.37</td>
<td valign="bottom" align="center">5.7</td>
</tr>
<tr>
<td valign="bottom" align="center">4</td>
<td valign="bottom" align="center">PLOS ONE</td>
<td valign="bottom" align="center">21</td>
<td valign="bottom" align="center">619</td>
<td valign="bottom" align="center">29.48</td>
<td valign="bottom" align="center">2.16</td>
<td valign="bottom" align="center">3.7</td>
</tr>
<tr>
<td valign="bottom" align="center">5</td>
<td valign="bottom" align="center">NUTRIENTS</td>
<td valign="bottom" align="center">17</td>
<td valign="bottom" align="center">201</td>
<td valign="bottom" align="center">11.82</td>
<td valign="bottom" align="center">1.75</td>
<td valign="bottom" align="center">5.9</td>
</tr>
<tr>
<td valign="bottom" align="center">6</td>
<td valign="bottom" align="center">BIOMEDICINE &amp; PHARMACOTHERAPY</td>
<td valign="bottom" align="center">16</td>
<td valign="bottom" align="center">290</td>
<td valign="bottom" align="center">18.12</td>
<td valign="bottom" align="center">1.65</td>
<td valign="bottom" align="center">7.5</td>
</tr>
<tr>
<td valign="bottom" align="center">7</td>
<td valign="bottom" align="center">SCIENTIFIC REPORTS</td>
<td valign="bottom" align="center">15</td>
<td valign="bottom" align="center">425</td>
<td valign="bottom" align="center">28.33</td>
<td valign="bottom" align="center">1.54</td>
<td valign="bottom" align="center">4.6</td>
</tr>
<tr>
<td valign="bottom" align="center">7</td>
<td valign="bottom" align="center">INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES</td>
<td valign="bottom" align="center">15</td>
<td valign="bottom" align="center">204</td>
<td valign="bottom" align="center">13.6</td>
<td valign="bottom" align="center">1.54</td>
<td valign="bottom" align="center">5.6</td>
</tr>
<tr>
<td valign="bottom" align="center">8</td>
<td valign="bottom" align="center">GUT MICROBES</td>
<td valign="bottom" align="center">13</td>
<td valign="bottom" align="center">542</td>
<td valign="bottom" align="center">41.69</td>
<td valign="bottom" align="center">1.34</td>
<td valign="bottom" align="center">12.2</td>
</tr>
<tr>
<td valign="bottom" align="center">9</td>
<td valign="bottom" align="center">FRONTIERS IN PHARMACOLOGY</td>
<td valign="bottom" align="center">12</td>
<td valign="bottom" align="center">58</td>
<td valign="bottom" align="center">4.83</td>
<td valign="bottom" align="center">1.23</td>
<td valign="bottom" align="center">5.6</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>
<xref ref-type="supplementary-material" rid="SF1">
<bold>Supplementary Figure 1</bold>
</xref> presents a bubble chart of the top 20 journals related to lung and intestinal microbiota research. The chart reveals that since 2021, <italic>Frontiers in Microbiology</italic>, <italic>Frontiers in Immunology</italic>, and <italic>Frontiers in Cellular and Infection Microbiology</italic> have been the most prolific journals in this research area. <italic>Plos One</italic> has maintained a steady publication volume since 2013, while <italic>Scientific Reports</italic> shows a general downward trend in publication volume. Specifically, <italic>Frontiers in Microbiology</italic> published 12 articles in this field in 2023.</p>
</sec>
<sec id="s3_6">
<label>3.6</label>
<title>Analysis of research areas</title>
<p>The research on lung diseases and intestinal microbiota encompasses 64 fields, with <xref ref-type="table" rid="T5">
<bold>Table&#xa0;5</bold>
</xref> listing the top 20 fields in publication volume. The fields of &#x201c;Microbiology&#x201d; and &#x201c;Immunology&#x201d; lead in publication volume, with 166 and 144 papers, respectively, and rank highest in total citations, with 6483 and 5025 citations each. The field with the highest average citation number is &#x201c;Virology&#x201d; (109.5 citations per paper), which, despite having a smaller publication volume of only 10 papers, has garnered relatively high attention and citations.</p>
<table-wrap id="T5" position="float">
<label>Table&#xa0;5</label>
<caption>
<p>Contribution of the top 10 research areas in intestinal microbiota and lung diseases.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="left">Rank</th>
<th valign="top" align="left">Research Field</th>
<th valign="top" align="left">Publications</th>
<th valign="top" align="left">Citations</th>
<th valign="top" align="left">H-index</th>
<th valign="top" align="left">Average Citations per Publication</th>
<th valign="top" align="left">The percentage of <break/>articles of institutions in total publications</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="bottom" align="right">1</td>
<td valign="bottom" align="left">Microbiology</td>
<td valign="bottom" align="right">166</td>
<td valign="bottom" align="right">6483</td>
<td valign="bottom" align="right">41</td>
<td valign="bottom" align="right">39.05</td>
<td valign="bottom" align="right">17.08</td>
</tr>
<tr>
<td valign="bottom" align="right">2</td>
<td valign="bottom" align="left">Immunology</td>
<td valign="bottom" align="right">144</td>
<td valign="bottom" align="right">5025</td>
<td valign="bottom" align="right">37</td>
<td valign="bottom" align="right">34.9</td>
<td valign="bottom" align="right">14.81</td>
</tr>
<tr>
<td valign="bottom" align="right">3</td>
<td valign="bottom" align="left">Pharmacology &amp; Pharmacy</td>
<td valign="bottom" align="right">89</td>
<td valign="bottom" align="right">944</td>
<td valign="bottom" align="right">16</td>
<td valign="bottom" align="right">10.61</td>
<td valign="bottom" align="right">9.16</td>
</tr>
<tr>
<td valign="bottom" align="right">4</td>
<td valign="bottom" align="left">Oncology</td>
<td valign="bottom" align="right">68</td>
<td valign="bottom" align="right">1544</td>
<td valign="bottom" align="right">20</td>
<td valign="bottom" align="right">22.71</td>
<td valign="bottom" align="right">7</td>
</tr>
<tr>
<td valign="bottom" align="right">5</td>
<td valign="bottom" align="left">Biochemistry &amp; Molecular Biology</td>
<td valign="bottom" align="right">62</td>
<td valign="bottom" align="right">2999</td>
<td valign="bottom" align="right">19</td>
<td valign="bottom" align="right">48.37</td>
<td valign="bottom" align="right">6.38</td>
</tr>
<tr>
<td valign="bottom" align="right">6</td>
<td valign="bottom" align="left">Respiratory System</td>
<td valign="bottom" align="right">60</td>
<td valign="bottom" align="right">1395</td>
<td valign="bottom" align="right">19</td>
<td valign="bottom" align="right">23.25</td>
<td valign="bottom" align="right">6.17</td>
</tr>
<tr>
<td valign="bottom" align="right">7</td>
<td valign="bottom" align="left">Medicine, Research &amp; Experimental</td>
<td valign="bottom" align="right">54</td>
<td valign="bottom" align="right">3226</td>
<td valign="bottom" align="right">20</td>
<td valign="bottom" align="right">59.74</td>
<td valign="bottom" align="right">5.56</td>
</tr>
<tr>
<td valign="bottom" align="right">8</td>
<td valign="bottom" align="left">Multidisciplinary Sciences</td>
<td valign="bottom" align="right">53</td>
<td valign="bottom" align="right">2140</td>
<td valign="bottom" align="right">20</td>
<td valign="bottom" align="right">40.38</td>
<td valign="bottom" align="right">5.45</td>
</tr>
<tr>
<td valign="bottom" align="right">9</td>
<td valign="bottom" align="left">Cell Biology</td>
<td valign="bottom" align="right">50</td>
<td valign="bottom" align="right">3257</td>
<td valign="bottom" align="right">21</td>
<td valign="bottom" align="right">65.14</td>
<td valign="bottom" align="right">5.14</td>
</tr>
<tr>
<td valign="bottom" align="right">10</td>
<td valign="bottom" align="left">Nutrition &amp; Dietetics</td>
<td valign="bottom" align="right">42</td>
<td valign="bottom" align="right">553</td>
<td valign="bottom" align="right">13</td>
<td valign="bottom" align="right">13.17</td>
<td valign="bottom" align="right">4.32</td>
</tr>
<tr>
<td valign="bottom" align="right">11</td>
<td valign="bottom" align="left">Gastroenterology &amp; Hepatology</td>
<td valign="bottom" align="right">29</td>
<td valign="bottom" align="right">1468</td>
<td valign="bottom" align="right">17</td>
<td valign="bottom" align="right">51.24</td>
<td valign="bottom" align="right">2.98</td>
</tr>
<tr>
<td valign="bottom" align="right">12</td>
<td valign="bottom" align="left">Medicine, General &amp; Internal</td>
<td valign="bottom" align="right">27</td>
<td valign="bottom" align="right">324</td>
<td valign="bottom" align="right">11</td>
<td valign="bottom" align="right">12</td>
<td valign="bottom" align="right">2.78</td>
</tr>
<tr>
<td valign="bottom" align="right">13</td>
<td valign="bottom" align="left">Integrative &amp; Complementary Medicine</td>
<td valign="bottom" align="right">25</td>
<td valign="bottom" align="right">116</td>
<td valign="bottom" align="right">7</td>
<td valign="bottom" align="right">4.64</td>
<td valign="bottom" align="right">2.57</td>
</tr>
<tr>
<td valign="bottom" align="right">14</td>
<td valign="bottom" align="left">Infectious Diseases</td>
<td valign="bottom" align="right">23</td>
<td valign="bottom" align="right">611</td>
<td valign="bottom" align="right">12</td>
<td valign="bottom" align="right">26.57</td>
<td valign="bottom" align="right">2.37</td>
</tr>
<tr>
<td valign="bottom" align="right">15</td>
<td valign="bottom" align="left">Food Science &amp; Technology</td>
<td valign="bottom" align="right">21</td>
<td valign="bottom" align="right">240</td>
<td valign="bottom" align="right">8</td>
<td valign="bottom" align="right">11.43</td>
<td valign="bottom" align="right">2.16</td>
</tr>
<tr>
<td valign="bottom" align="right">16</td>
<td valign="bottom" align="left">Chemistry, Multidisciplinary</td>
<td valign="bottom" align="right">21</td>
<td valign="bottom" align="right">303</td>
<td valign="bottom" align="right">10</td>
<td valign="bottom" align="right">14.43</td>
<td valign="bottom" align="right">2.16</td>
</tr>
<tr>
<td valign="bottom" align="right">17</td>
<td valign="bottom" align="left">Biotechnology &amp; Applied Microbiology</td>
<td valign="bottom" align="right">21</td>
<td valign="bottom" align="right">333</td>
<td valign="bottom" align="right">12</td>
<td valign="bottom" align="right">15.86</td>
<td valign="bottom" align="right">2.16</td>
</tr>
<tr>
<td valign="bottom" align="right">18</td>
<td valign="bottom" align="left">Environmental Sciences</td>
<td valign="bottom" align="right">16</td>
<td valign="bottom" align="right">110</td>
<td valign="bottom" align="right">6</td>
<td valign="bottom" align="right">6.88</td>
<td valign="bottom" align="right">1.65</td>
</tr>
<tr>
<td valign="bottom" align="right">19</td>
<td valign="bottom" align="left">Pediatrics</td>
<td valign="bottom" align="right">16</td>
<td valign="bottom" align="right">217</td>
<td valign="bottom" align="right">9</td>
<td valign="bottom" align="right">13.56</td>
<td valign="bottom" align="right">1.65</td>
</tr>
<tr>
<td valign="bottom" align="right">20</td>
<td valign="bottom" align="left">Toxicology</td>
<td valign="bottom" align="right">15</td>
<td valign="bottom" align="right">67</td>
<td valign="bottom" align="right">5</td>
<td valign="bottom" align="right">4.47</td>
<td valign="bottom" align="right">1.54</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>
<xref ref-type="supplementary-material" rid="SF2">
<bold>Supplementary Figure 2</bold>
</xref> presents a bubble chart sorted by publication volume for the top 20 research fields. According to the chart, &#x201c;Microbiology&#x201d; and &#x201c;Immunology&#x201d; have been the most popular research fields since 2011. Since 2018, there has been a rising trend in the publication volume in fields such as &#x201c;Pharmacology &amp; Pharmacy,&#x201d; &#x201c;Oncology,&#x201d; &#x201c;Biochemistry &amp; Molecular Biology,&#x201d; &#x201c;Respiratory System,&#x201d; &#x201c;Medicine, Research &amp; Experimental,&#x201d; &#x201c;Multidisciplinary Sciences,&#x201d; and &#x201c;Cell Biology.&#x201d; This trend indicates increasing attention in these areas.</p>
</sec>
<sec id="s3_7">
<label>3.7</label>
<title>Analysis of author keywords</title>
<p>An analysis was conducted on 1,046 author keywords, with &#x201c;intestinal microbiota/microbiome,&#x201d; &#x201c;microbiota/microbiome,&#x201d; and &#x201c;gut-lung axis&#x201d; being the keywords that appeared over 100 times (<xref ref-type="table" rid="T6">
<bold>Table&#xa0;6</bold>
</xref>). As shown in the bubble chart of <xref ref-type="supplementary-material" rid="SF3">
<bold>Supplementary Figure 3</bold>
</xref>, since the outbreak of COVID-19/SARS-CoV-2 in 2020, it has become a focal point of interest.</p>
<table-wrap id="T6" position="float">
<label>Table&#xa0;6</label>
<caption>
<p>Contribution of the top 10 author keywords in intestinal microbiota and lung diseases.</p>
</caption>
<table frame="hsides">
<thead>
<tr>
<th valign="top" align="center">Rank</th>
<th valign="top" align="center">Authorkeywords</th>
<th valign="top" align="center">Total Publications</th>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="center">1</td>
<td valign="top" align="center">intestinal microbiota/microbiome</td>
<td valign="top" align="center">333</td>
</tr>
<tr>
<td valign="top" align="center">2</td>
<td valign="top" align="center">microbiota/microbiome</td>
<td valign="top" align="center">178</td>
</tr>
<tr>
<td valign="top" align="center">3</td>
<td valign="top" align="center">gut-lung axis</td>
<td valign="top" align="center">132</td>
</tr>
<tr>
<td valign="top" align="center">4</td>
<td valign="top" align="center">COVID-19/SARS-CoV-2</td>
<td valign="top" align="center">81</td>
</tr>
<tr>
<td valign="top" align="center">5</td>
<td valign="top" align="center">probiotics</td>
<td valign="top" align="center">64</td>
</tr>
<tr>
<td valign="top" align="center">6</td>
<td valign="top" align="center">inflammation</td>
<td valign="top" align="center">60</td>
</tr>
<tr>
<td valign="top" align="center">7</td>
<td valign="top" align="center">asthma</td>
<td valign="top" align="center">57</td>
</tr>
<tr>
<td valign="top" align="center">8</td>
<td valign="top" align="center">short-chain fatty acids</td>
<td valign="top" align="center">47</td>
</tr>
<tr>
<td valign="top" align="center">9</td>
<td valign="top" align="center">lung cancer</td>
<td valign="top" align="center">44</td>
</tr>
<tr>
<td valign="top" align="center">10</td>
<td valign="top" align="center">dysbiosis</td>
<td valign="top" align="center">39</td>
</tr>
</tbody>
</table>
</table-wrap>
<p>Using CiteSpace software, the keywords were categorized into 11 clusters (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7</bold>
</xref>). Closely related keywords were automatically grouped into a cluster, with each cluster named after the keyword with the highest log-likelihood ratio (LLR). The higher the LLR, the more representative the keyword is of its cluster. The 11 clusters identified in this field are #0 asthma, #1 probiotics, #2 non-small cell lung cancer, #3 inflammation, #4 metagenomics, #5 COPD, #6 immunity, #7 gut, #8 pulmonary hypertension, #9 gut-lung axis, and #10 sepsis, with cluster #0 being the largest.</p>
<fig id="f7" position="float">
<label>Figure&#xa0;7</label>
<caption>
<p>The clustered network map of author keywords in intestinal microbiota and lung diseases.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-14-1347110-g007.tif"/>
</fig>
<p>A timeline chart was created based on the first year of the appearance of the keywords (<xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8</bold>
</xref>). In this field, the earliest active cluster was #9, followed by the rise of #1. Our study identified 5 keywords with the most potent citation bursts (<xref ref-type="fig" rid="f9">
<bold>Figure&#xa0;9</bold>
</xref>), including asthma, lung, airway hyperresponsiveness, allergy, and non-small cell lung cancer.</p>
<fig id="f8" position="float">
<label>Figure&#xa0;8</label>
<caption>
<p>The timeline of clustered network map of author keywords in intestinal microbiota and lung diseases.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-14-1347110-g008.tif"/>
</fig>
<fig id="f9" position="float">
<label>Figure&#xa0;9</label>
<caption>
<p>All author keywords with the strongest citation bursts in intestinal microbiota and lung diseases.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-14-1347110-g009.tif"/>
</fig>
</sec>
<sec id="s3_8">
<label>3.8</label>
<title>Analysis of ESI highly cited papers and citation bursts references</title>
<p>
<xref ref-type="fig" rid="f10">
<bold>Figure&#xa0;10</bold>
</xref> displays a network visualization map of cited references, with yellow nodes representing the most recently appearing keywords, indicating these are the latest cited references in the field. <xref ref-type="fig" rid="f11">
<bold>Figure&#xa0;11</bold>
</xref> shows 12 related clusters identified by CiteSpace: COVID-19/SARS-CoV-2, COPD, chronic pulmonary disease, immunotherapy, asthma, sepsis, tuberculosis, lung cancer, cystic fibrosis, anti-tuberculosis therapy, pulmonary hypertension, and Th1 and M1 polarization.</p>
<fig id="f10" position="float">
<label>Figure&#xa0;10</label>
<caption>
<p>Reference co-citation network in intestinal microbiota and lung diseases.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-14-1347110-g010.tif"/>
</fig>
<fig id="f11" position="float">
<label>Figure&#xa0;11</label>
<caption>
<p>The clustered network map of co-cited references in intestinal microbiota and lung diseases.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-14-1347110-g011.tif"/>
</fig>
<p>A burst strength analysis of the references was conducted using CiteSpace to gain a comprehensive understanding of the cited references. The time frame was set from 2011 to 2023, with a one-year interval, and 40 references with significant burst strength were identified. Among these, 8 references had a burst strength more significant than 10 (<xref ref-type="fig" rid="f12">
<bold>Figure&#xa0;12</bold>
</xref>). This analysis highlights the most influential and rapidly emerging topics in the field within the specified time frame.</p>
<fig id="f12" position="float">
<label>Figure&#xa0;12</label>
<caption>
<p>Top 40 references with the strongest citation bursts in intestinal microbiota and lung diseases.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-14-1347110-g012.tif"/>
</fig>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<label>4</label>
<title>Discussion</title>
<sec id="s4_1">
<label>4.1</label>
<title>General information</title>
<p>In this study, we analyzed 794 articles from the WoSCC database in the field of lung diseases and intestinal microbiota using Python, VOSviewer, and CiteSpace. The research findings indicate a significant increase in annual publications and citation numbers starting from 2020, with a predominant contribution from China. This highlights the extensive research contributions of China in this field. Among the top 10 institutions in terms of publications, 9 are from China, including Zhejiang University, Fudan University, Shanghai Jiao Tong University, Sun Yat-sen University, Capital Medical University, Beijing University of Traditional Chinese Medicine, Chinese Academy of Sciences, Guangzhou Medical University, and Southeast University. This indicates increasing attention and emphasis on this research area in China.</p>
<p>In terms of publication volume, the most prolific author is Jian Wang from China. However, in terms of total citations, Benjamin J Marsland from Monash University, Australia, holds the leading position but is outside the top 10 authors. Following him are Eva S Gollwitzer from Universitaire Vaudois, Switzerland, and Aurelien Trompette. In terms of the H-index, the leading positions are occupied by Valentin Sencio and Francois Trottein. When assessing prolific authors, it is crucial to consider the quantity of their publications and the quality of the articles.</p>
<p>From the perspective of journals, <italic>Frontiers in Microbiology</italic> holds a leading position as the journal with the highest number of publications in this field. However, <italic>Nature Medicine</italic> has the highest total citations despite publishing only three articles. This discrepancy highlights the significant impact and high quality of the articles in <italic>Nature Medicine</italic>.</p>
<p>The most focused research fields are &#x201c;Microbiology&#x201d; and &#x201c;Immunology&#x201d;, which lead in both the number of publications and total citations. Despite having fewer publications, the field of &#x201c;Virology&#x201d; has the highest average citation count. This heightened attention and citation rate could be related to the outbreak of COVID-19/SARS-CoV-2 in 2020, which has also become a focal point of interest.</p>
<p>Benjamin J Marsland from Monash University is a prominent author in terms of citations in this field. His long-term research into the impact of the microbiome on human immunity and the respiratory system has been influential. His team discovered a new protective pathway within the gut-lung axis - L-tyrosine&#x2013;PCS, which can be used to treat or prevent inflammatory diseases (<xref ref-type="bibr" rid="B79">Wypych et&#xa0;al., 2021</xref>). This discovery underscores the critical interplay between intestinal microbiota and lung health, revealing novel pathways for therapeutic interventions.</p>
</sec>
<sec id="s4_2">
<label>4.2</label>
<title>Research hotspots and trends</title>
<p>The lung and intestinal microbiota fields have consistently attracted attention from scholars worldwide. Current research hotspots, identified through analyses of the most-cited references, keyword co-occurrence, clustering, and emerging trends, primarily focus on the gut-lung axis, probiotics, COVID-19, asthma, and COPD. It is well-recognized that intestinal microbiota dysbiosis is associated with increased susceptibility to respiratory diseases and alterations in lung immune responses and homeostasis. Although an increasing number of epidemiological and experimental studies have highlighted the relationship between the intestinal microbiome and the lungs, referred to as the &#x201c;gut-lung axis&#x201d; (<xref ref-type="bibr" rid="B5">Bingula et&#xa0;al., 2017</xref>; <xref ref-type="bibr" rid="B15">Dang and Marsland, 2019</xref>), the mechanisms by which intestinal microbiota influence lung diseases remain unclear (<xref ref-type="bibr" rid="B7">Budden et&#xa0;al., 2017</xref>). Understanding these mechanisms is crucial for developing effective treatments and prevention strategies for respiratory diseases influenced by intestinal microbiota.</p>
<sec id="s4_2_1">
<label>4.2.1</label>
<title>SCFAs</title>
<p>The human gut harbors a rich and diverse microbial community, predominantly constituted by the intestinal microbiota. The dominant phyla within this community include Firmicutes (e.g., Clostridia, Lactobacillus) and Bacteroidetes (e.g., Bacteroides, Prevotella) (<xref ref-type="bibr" rid="B1">Adak and Khan, 2019</xref>). Research into the human microbiome has shown that the intestinal microbiota plays a crucial role in maintaining homeostasis in the gastrointestinal system and distant organs by modulating immune responses. It is critical to host health and intestinal immune homeostasis (<xref ref-type="bibr" rid="B67">Tan et&#xa0;al., 2014</xref>). However, intestinal microbiota dysbiosis can impact lung diseases, such as pneumonia, asthma, lung cancer, COPD (Chronic Obstructive Pulmonary Disease), and PH (Pulmonary Hypertension). This influence is likely related to alterations in immune responses, hormonal balance, and metabolic homeostasis (<xref ref-type="bibr" rid="B4">Bander et&#xa0;al., 2020</xref>; <xref ref-type="bibr" rid="B44">Ma et&#xa0;al., 2022</xref>).</p>
<p>Short-chain fatty acids (SCFAs) are among the most abundant microbial metabolites in the gut, playing fundamental roles such as lowering intestinal pH and promoting mucin synthesis. These functions prevent the adherence of harmful bacteria, enhance epithelial integrity, and strengthen the host&#x2019;s immune system (<xref ref-type="bibr" rid="B3">Ashique et&#xa0;al., 2022</xref>). SCFAs interact with G-protein-coupled receptors (GPCRs) and regulate the differentiation of Treg, Th1, and Th17 cells. They also inhibit histone deacetylases (HDACs), thereby controlling cytokine storms and excessive immune responses, making them essential regulators in immune responses, inflammation, and the development of lung diseases (<xref ref-type="bibr" rid="B32">Jardou and Lawson, 2021</xref>; <xref ref-type="bibr" rid="B62">Smith et&#xa0;al., 2013</xref>; <xref ref-type="bibr" rid="B11">Castro-Mej&#xed;a et&#xa0;al., 2018</xref>; <xref ref-type="bibr" rid="B34">Kleiner et&#xa0;al., 2015</xref>; <xref ref-type="bibr" rid="B68">Tang et&#xa0;al., 2021</xref>; <xref ref-type="bibr" rid="B6">Brown et&#xa0;al., 2017</xref>). However, not all studies report the anti-inflammatory actions of SCFAs. They have also been shown to increase the production of pro-inflammatory cytokines in cells stimulated by toll-like receptors (TLRs) (<xref ref-type="bibr" rid="B57">Rutting et&#xa0;al., 2019</xref>; <xref ref-type="bibr" rid="B49">Mirmonsef et&#xa0;al., 2012</xref>). Further research by <xref ref-type="bibr" rid="B24">Ghorbani et&#xa0;al. (2015)</xref> suggests that SCFAs can have anti-inflammatory and pro-inflammatory effects on lung cells. This dual role indicates that the therapeutic value of SCFAs in treating and managing diseases, particularly those involving the lung, is a promising area for further exploration. The complex nature of SCFA interactions in the human body, especially in the context of the gut-lung axis, highlights the importance of a nuanced understanding of these metabolites in health and disease.</p>
</sec>
<sec id="s4_2_2">
<label>4.2.2</label>
<title>Airway microbiome</title>
<p>Research suggests that gut microbiota influence the composition of airway microbiota through their metabolic products, such as short-chain fatty acids (SCFAs), and immune cells (<xref ref-type="bibr" rid="B56">Reyes et&#xa0;al., 2012</xref>; <xref ref-type="bibr" rid="B12">Chakradhar, 2017</xref>; <xref ref-type="bibr" rid="B9">Cait et&#xa0;al., 2018</xref>; <xref ref-type="bibr" rid="B63">Steed et&#xa0;al., 2017</xref>; <xref ref-type="bibr" rid="B58">Samuelson et&#xa0;al., 2015</xref>; <xref ref-type="bibr" rid="B30">Herbst et&#xa0;al., 2011</xref>; <xref ref-type="bibr" rid="B26">Grayson et&#xa0;al., 2018</xref>). Compared to gut microbiota, research on airway microbiota is still in its infancy, but interest in this area is gradually increasing (<xref ref-type="bibr" rid="B15">Dang and Marsland, 2019</xref>). Rapid advancements in high-throughput sequencing technologies have corrected the misconception that &#x201c;healthy lungs are sterile,&#x201d; making airway microbiomics a focus of current research. Multiple studies have confirmed that the lungs are not a sterile environment, although the microbial load in the airways is significantly lower than in the gut (<xref ref-type="bibr" rid="B80">Yagi et&#xa0;al., 2021</xref>; <xref ref-type="bibr" rid="B54">Rastogi et&#xa0;al., 2022</xref>). A mature airway microbiome is equally important for the development and regulation of adaptive and innate immune responses (<xref ref-type="bibr" rid="B19">Enaud et&#xa0;al., 2020</xref>; <xref ref-type="bibr" rid="B52">Pattaroni et&#xa0;al., 2018</xref>). Increasingly, research is showing a link between airway microbiota and respiratory diseases (such as ventilator-associated pneumonia, asthma, chronic obstructive pulmonary disease) as well as metabolic diseases (such as obesity, diabetes) (<xref ref-type="bibr" rid="B60">Shah and Bunyavanich, 2021</xref>; <xref ref-type="bibr" rid="B31">Huang and Shi, 2019</xref>; <xref ref-type="bibr" rid="B69">Tiew et&#xa0;al., 2021</xref>; <xref ref-type="bibr" rid="B35">Lee et&#xa0;al., 2019</xref>; <xref ref-type="bibr" rid="B46">Martin-Loeches et&#xa0;al., 2020</xref>; <xref ref-type="bibr" rid="B70">Trompette et&#xa0;al., 2014</xref>; <xref ref-type="bibr" rid="B21">Fenn et&#xa0;al., 2022</xref>). Comparing the airway microbiome composition of healthy individuals and patients with diseases can reveal specific microbial communities associated with the onset and progression of diseases. Reviews by <xref ref-type="bibr" rid="B80">Yagi et&#xa0;al. (2021)</xref> suggest that the airway microbiome could become a useful biomarker for respiratory diseases in clinical settings. Therefore, investigating the role of airway microbiota dysbiosis in various lung diseases is crucial.</p>
<p>Researchers have delved into the functions of airway microbiota within the body. They have found that certain microbes can positively impact respiratory health by producing specific metabolic products or participating in immune responses. Additionally, airway microbiota interact with host cells, influencing disease progression by regulating host gene expression (<xref ref-type="bibr" rid="B83">Yuan et&#xa0;al., 2022</xref>; <xref ref-type="bibr" rid="B15">Dang and Marsland, 2019</xref>; <xref ref-type="bibr" rid="B74">Ver Heul et&#xa0;al., 2019</xref>; <xref ref-type="bibr" rid="B81">Yan et&#xa0;al., 2022</xref>; <xref ref-type="bibr" rid="B59">Sequeira et&#xa0;al., 2020</xref>; <xref ref-type="bibr" rid="B6">Brown et&#xa0;al., 2017</xref>; <xref ref-type="bibr" rid="B64">Subramaniam et&#xa0;al., 2015</xref>). With the widespread use of broad-spectrum antibiotics, increasing numbers of antibiotic-resistant strains are emerging in the airway microbiota. Researchers are studying the transmission pathways of antibiotic resistance genes in airway microbiota and the mechanisms of resistant strain formation to better manage antibiotic use and develop new treatment strategies (<xref ref-type="bibr" rid="B41">Lin et&#xa0;al., 2023</xref>; <xref ref-type="bibr" rid="B8">Cai et&#xa0;al., 2022</xref>; <xref ref-type="bibr" rid="B40">Lin et&#xa0;al., 2021</xref>; <xref ref-type="bibr" rid="B13">Chmiel et&#xa0;al., 2014</xref>; <xref ref-type="bibr" rid="B61">Sherrard et&#xa0;al., 2014</xref>; <xref ref-type="bibr" rid="B45">Mac Aog&#xe1;in et&#xa0;al., 2020</xref>). Recent research indicates that the airway microbiome could spread through airborne transmission, direct contact, or other routes among people, particularly since the COVID-19 outbreak (<xref ref-type="bibr" rid="B18">Doggett et&#xa0;al., 2020</xref>). This finding is significant for disease control, as intervening in the transmission pathways of the airway microbiome could help prevent the spread of diseases.</p>
</sec>
<sec id="s4_2_3">
<label>4.2.3</label>
<title>Probiotics</title>
<p>Keyword cluster analysis has revealed that probiotics are an emerging research hotspot in the study of the relationship between intestinal bacteria and lung diseases. Probiotics, beneficial microorganisms, selectively stimulate the growth and activity of a limited number of bacteria in the gut (<xref ref-type="bibr" rid="B16">da Silva et&#xa0;al., 2021</xref>). Primarily, this refers to species within the Lactobacillus and Bifidobacterium genera in the intestine. Probiotics play multiple roles within the human body: they aid in breaking down complex substances in food, promoting digestion and absorption. Additionally, they produce enzymes and substances that enhance the utilization of nutrients in food. Probiotics can competitively occupy ecological niches in the gut, inhibiting the growth of harmful bacteria and reducing pathogenic attacks and infections on the host. They also stimulate and regulate the function of the host&#x2019;s immune system, enhancing the body&#x2019;s immunity and helping to fend off diseases (<xref ref-type="bibr" rid="B55">Reid et&#xa0;al., 2017</xref>; <xref ref-type="bibr" rid="B39">Licciardi et&#xa0;al., 2012</xref>). Probiotics produce beneficial metabolic products, such as short-chain fatty acids, which regulate the intestinal pH balance and maintain gut health (<xref ref-type="bibr" rid="B33">Kim et&#xa0;al., 2019</xref>; <xref ref-type="bibr" rid="B53">Ragan et&#xa0;al., 2022</xref>; <xref ref-type="bibr" rid="B82">Yan and Polk, 2020</xref>). Modulating the composition of the gut microbiota, adjusting the metabolic products of gut microbes, and improving intestinal barrier function are potential regulatory mechanisms of probiotics (<xref ref-type="bibr" rid="B37">Li et&#xa0;al., 2021</xref>; <xref ref-type="bibr" rid="B78">Wang X. et&#xa0;al., 2021</xref>). Professor Matsuzaki demonstrated the efficacy of probiotics as early as 1985 (<xref ref-type="bibr" rid="B47">Matsuzaki et&#xa0;al., 1985</xref>). However, current research on the role of probiotics in lung diseases is relatively limited, and more studies are needed to confirm their effects in this context.</p>
</sec>
</sec>
<sec id="s4_3">
<label>4.3</label>
<title>Future research directions</title>
<p>The gut-lung axis is an emerging field with many aspects yet to be fully understood. Future research aims to delve deeper into understanding the gut microbiota and its metabolic products, airway microbiota and their metabolites, and to develop suitable bioinformatics and machine learning models. These models are intended to predict and assess various gut-lung axis diseases and health statuses, leading to the development of personalized prevention and treatment strategies (<xref ref-type="bibr" rid="B85">Zheng et&#xa0;al., 2020</xref>; <xref ref-type="bibr" rid="B84">Zheng et&#xa0;al., 2023</xref>; <xref ref-type="bibr" rid="B38">Liang et&#xa0;al., 2022</xref>). Recent discoveries indicate significant differences in the gut microbiota of lung cancer patients compared to their lung microbiome communities. Changes in the gut microbiota can affect the prognosis and treatment outcomes of lung cancer (<xref ref-type="bibr" rid="B25">Goto, 2022</xref>; <xref ref-type="bibr" rid="B72">Tsay et&#xa0;al., 2021</xref>; <xref ref-type="bibr" rid="B71">Tsay et&#xa0;al., 2018</xref>), making the role of the gut-lung axis in the prevention, diagnosis, and treatment of lung cancer a valuable area of exploration. Dietary habits have been found to influence the gut microbiota, thereby impacting the prevention and treatment of lung diseases (<xref ref-type="bibr" rid="B23">Gasmi et&#xa0;al., 2021</xref>; <xref ref-type="bibr" rid="B29">Healy et&#xa0;al., 2021</xref>). Understanding the relationship between nutrition and the gut-lung axis, and designing specific dietary plans, may be one of the future research directions. COVID-19, one of the most widely discussed diseases in recent years, has been shown to be influenced by the gut microbiota, which may affect the host&#x2019;s infection and immune response to the virus (<xref ref-type="bibr" rid="B77">Wang H. et&#xa0;al., 2021</xref>; <xref ref-type="bibr" rid="B48">McGinniss and Collman, 2021</xref>; <xref ref-type="bibr" rid="B42">Liu et&#xa0;al., 2022</xref>; <xref ref-type="bibr" rid="B2">Ancona et&#xa0;al., 2023</xref>). Therefore, studying the relationship between the gut-lung axis and COVID-19 is of significant importance for the prevention and treatment of this disease. This line of research holds the potential to unlock new insights into managing not only COVID-19 but also other respiratory diseases influenced by the complex interactions within the gut-lung axis.</p>
</sec>
<sec id="s4_4">
<label>4.4</label>
<title>Strengths and limitations</title>
<p>Our study leveraged bibliometric methods to perform a visual analysis of research on the relationship between intestinal microbiota and lung diseases, aiding scholars in better understanding the hotspots and trends in this field. However, our study also has limitations. We analyzed only articles published on WoSCC within a specific timeframe and in English, potentially overlooking research results from other databases. Despite this, using visual methods to understand the current state, hotspots, and trends in a field remains valuable.</p>
</sec>
</sec>
<sec id="s5" sec-type="conclusions">
<label>5</label>
<title>Conclusion</title>
<p>Using Python programming, VOSviewer, and CiteSpace software, we conducted a bibliometric study on articles related to the gut microbiota and lung diseases. The results indicate an upward trend in research volume in this field since 2011, signifying the burgeoning development of theories related to the lung and gut microbiota. China has the highest total publication volume in this area, while the quality of articles from the United States is comparatively higher. The correlation and potential mechanisms between the gut microbiota and lung diseases, including asthma, COPD, lung cancer, and respiratory infections, remain hot research topics. However, the understanding of the mechanisms involved in the gut-lung axis is still in its nascent stages and requires further elucidation. Future research needs to focus more on the gut microbiota and airway microbiota to enhance our understanding of the gut-lung axis. This deeper understanding is crucial for developing new and effective treatment strategies for lung diseases. As this field continues to evolve, it&#x2019;s evident that interdisciplinary research encompassing microbiology, immunology, and respiratory medicine will be pivotal in unlocking new insights into the gut-lung axis and its implications for human health.</p>
</sec>
<sec id="s6" sec-type="data-availability">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="supplementary-material" rid="s11">
<bold>Supplementary Material</bold>
</xref>. Further inquiries can be directed to the corresponding authors.</p>
</sec>
<sec id="s7" sec-type="author-contributions">
<title>Author contributions</title>
<p>WS: Writing &#x2013; original draft. TZ: Writing &#x2013; review &amp; editing. PD: Writing &#x2013; review &amp; editing. LG: Writing &#x2013; review &amp; editing. XZ: Writing &#x2013; review &amp; editing. KL: Writing &#x2013; review &amp; editing.</p>
</sec>
</body>
<back>
<sec id="s8" sec-type="funding-information">
<title>Funding</title>
<p>The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This study was supported by the Science and Technology Department of Sichuan Province (No. 2022YFS0388, 23ZYZYTS0231).</p>
</sec>
<sec id="s9" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s10" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s11" sec-type="supplementary-material">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fcimb.2024.1347110/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fcimb.2024.1347110/full#supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="Image_1.tif" id="SF1" mimetype="image/tiff">
<label>Supplementary Figure&#xa0;1</label>
<caption>
<p>Bubble chart of the top 20 journals by year.</p>
</caption>
</supplementary-material>
<supplementary-material xlink:href="Image_2.tif" id="SF2" mimetype="image/tiff">
<label>Supplementary Figure&#xa0;2</label>
<caption>
<p>Bubble chart of the top 20 research areas by year.</p>
</caption>
</supplementary-material>
<supplementary-material xlink:href="Image_3.tif" id="SF3" mimetype="image/tiff">
<label>Supplementary Figure&#xa0;3</label>
<caption>
<p>Bubble chart of the top 30 author keywords by year.</p>
</caption>
</supplementary-material>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Adak</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Khan</surname> <given-names>M. R.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>An insight into gut microbiota and its functionalities</article-title>. <source>Cell Mol. Life Sci.</source> <volume>76</volume>, <fpage>473</fpage>&#x2013;<lpage>493</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00018-018-2943-4</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ancona</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Alagna</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Alteri</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Palomba</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Tonizzo</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Pastena</surname> <given-names>A.</given-names>
</name>
<etal/>
</person-group>. (<year>2023</year>). <article-title>Gut and airway microbiota dysbiosis and their role in COVID-19 and long-COVID</article-title>. <source>Front. Immunol.</source> <volume>14</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2023.1080043</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ashique</surname> <given-names>S.</given-names>
</name>
<name>
<surname>De Rubis</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Sirohi</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Mishra</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Rihan</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Garg</surname> <given-names>A.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>Short Chain Fatty Acids: Fundamental mediators of the gut-lung axis and their involvement in pulmonary diseases</article-title>. <source>Chem. Biol. Interact.</source> <volume>368</volume>, <elocation-id>110231</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cbi.2022.110231</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bander</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Nitert</surname> <given-names>M. D.</given-names>
</name>
<name>
<surname>Mousa</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Naderpoor</surname> <given-names>N.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>The gut microbiota and inflammation: an overview</article-title>. <source>Int. J. Environ. Res. Public Health</source> <volume>17</volume>, <elocation-id>7618</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijerph17207618</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bingula</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Filaire</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Radosevic-Robin</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Bey</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Berthon</surname> <given-names>J. Y.</given-names>
</name>
<name>
<surname>Bernalier-Donadille</surname> <given-names>A.</given-names>
</name>
<etal/>
</person-group>. (<year>2017</year>). <article-title>Desired turbulence? Gut-lung axis, immunity, and lung cancer</article-title>. <source>J. Oncol.</source> <volume>2017</volume>, <elocation-id>5035371</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1155/2017/5035371</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brown</surname> <given-names>R. L.</given-names>
</name>
<name>
<surname>Sequeira</surname> <given-names>R. P.</given-names>
</name>
<name>
<surname>Clarke</surname> <given-names>T. B.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>The microbiota protects against respiratory infection via GM-CSF signaling</article-title>. <source>Nat. Commun.</source> <volume>8</volume>, <fpage>1512</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41467-017-01803-x</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Budden</surname> <given-names>K. F.</given-names>
</name>
<name>
<surname>Gellatly</surname> <given-names>S. L.</given-names>
</name>
<name>
<surname>Wood</surname> <given-names>D. L.</given-names>
</name>
<name>
<surname>Cooper</surname> <given-names>M. A.</given-names>
</name>
<name>
<surname>Morrison</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Hugenholtz</surname> <given-names>P.</given-names>
</name>
<etal/>
</person-group>. (<year>2017</year>). <article-title>Emerging pathogenic links between microbiota and the gut-lung axis</article-title>. <source>Nat. Rev. Microbiol.</source> <volume>15</volume>, <fpage>55</fpage>&#x2013;<lpage>63</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nrmicro.2016.142</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cai</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Luo</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Cao</surname> <given-names>Z.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>Airway microecology in rifampicin-resistant and rifampicin-sensitive pulmonary tuberculosis patients</article-title>. <source>BMC Microbiol.</source> <volume>22</volume>, <elocation-id>286</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12866-022-02705-9</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cait</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Hughes</surname> <given-names>M. R.</given-names>
</name>
<name>
<surname>Antignano</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Cait</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Dimitriu</surname> <given-names>P. A.</given-names>
</name>
<name>
<surname>Maas</surname> <given-names>K. R.</given-names>
</name>
<etal/>
</person-group>. (<year>2018</year>). <article-title>Microbiome-driven allergic lung inflammation is ameliorated by short-chain fatty acids</article-title>. <source>Mucosal Immunol.</source> <volume>11</volume>, <fpage>785</fpage>&#x2013;<lpage>795</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/mi.2017.75</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Carding</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Verbeke</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Vipond</surname> <given-names>D. T.</given-names>
</name>
<name>
<surname>Corfe</surname> <given-names>B. M.</given-names>
</name>
<name>
<surname>Owen</surname> <given-names>L. J.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Dysbiosis of the gut microbiota in disease</article-title>. <source>Microb. Ecol. Health Dis.</source> <volume>26</volume>, <elocation-id>26191</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3402/mehd.v26.26191</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Castro-Mej&#xed;a</surname> <given-names>J. L.</given-names>
</name>
<name>
<surname>Deng</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Vogensen</surname> <given-names>F. K.</given-names>
</name>
<name>
<surname>Reyes</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Nielsen</surname> <given-names>D. S.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Extraction and purification of viruses from fecal samples for metagenome and morphology analyses</article-title>. <source>Methods Mol. Biol.</source> <volume>1838</volume>, <fpage>49</fpage>&#x2013;<lpage>57</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/978-1-4939-8682-8_5</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chakradhar</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>A curious connection: Teasing apart the link between gut microbes and lung disease</article-title>. <source>Nat. Med.</source> <volume>23</volume>, <fpage>402</fpage>&#x2013;<lpage>404</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nm0417-402</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chmiel</surname> <given-names>J. F.</given-names>
</name>
<name>
<surname>Aksamit</surname> <given-names>T. R.</given-names>
</name>
<name>
<surname>Chotirmall</surname> <given-names>S. H.</given-names>
</name>
<name>
<surname>Dasenbrook</surname> <given-names>E. C.</given-names>
</name>
<name>
<surname>Elborn</surname> <given-names>J. S.</given-names>
</name>
<name>
<surname>LiPuma</surname> <given-names>J. J.</given-names>
</name>
<etal/>
</person-group>. (<year>2014</year>). <article-title>Antibiotic management of lung infections in cystic fibrosis. I. The microbiome, methicillin-resistant Staphylococcus aureus, gram-negative bacteria, and multiple infections</article-title>. <source>Ann. Am. Thorac. Soc.</source> <volume>11</volume>, <fpage>1120</fpage>&#x2013;<lpage>1129</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1513/AnnalsATS.201402-050AS</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Clemente</surname> <given-names>J. C.</given-names>
</name>
<name>
<surname>Ursell</surname> <given-names>L. K.</given-names>
</name>
<name>
<surname>Parfrey</surname> <given-names>L. W.</given-names>
</name>
<name>
<surname>Knight</surname> <given-names>R.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>The impact of the gut microbiota on human health: an integrative view</article-title>. <source>Cell</source> <volume>148</volume>, <fpage>1258</fpage>&#x2013;<lpage>1270</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cell.2012.01.035</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dang</surname> <given-names>A. T.</given-names>
</name>
<name>
<surname>Marsland</surname> <given-names>B. J.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Microbes, metabolites, and the gut-lung axis</article-title>. <source>Mucosal Immunol.</source> <volume>2</volume>, <fpage>843</fpage>&#x2013;<lpage>850</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41385-019-0160-6</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>da Silva</surname> <given-names>T. F.</given-names>
</name>
<name>
<surname>Casarotti</surname> <given-names>S. N.</given-names>
</name>
<name>
<surname>de Oliveira</surname> <given-names>G. L. V.</given-names>
</name>
<name>
<surname>Penna</surname> <given-names>A. L. B.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>The impact of probiotics, prebiotics, and synbiotics on the biochemical, clinical, and immunological markers, as well as on the gut microbiota of obese hosts</article-title>. <source>Crit. Rev. Food Sci. Nutr.</source> <volume>61</volume>, <fpage>337</fpage>&#x2013;<lpage>355</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/10408398.2020.1733483</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>de Steenhuijsen Piters</surname> <given-names>W. A.</given-names>
</name>
<name>
<surname>Sanders</surname> <given-names>E. A.</given-names>
</name>
<name>
<surname>Bogaert</surname> <given-names>D.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>The role of the local microbial ecosystem in respiratory health and disease</article-title>. <source>Philos. Trans. R Soc. Lond B Biol. Sci.</source> <volume>370</volume>, <fpage>20140294</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1098/rstb.2014.0294</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Doggett</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Chow</surname> <given-names>C. W.</given-names>
</name>
<name>
<surname>Mubareka</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Characterization of experimental and clinical bioaerosol generation during potential aerosol-generating procedures</article-title>. <source>Chest</source> <volume>158</volume>, <fpage>2467</fpage>&#x2013;<lpage>2473</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.chest.2020.07.026</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Enaud</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Prevel</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Ciarlo</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Beaufils</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Wie&#xeb;rs</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Guery</surname> <given-names>B.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>The gut-lung axis in health and respiratory diseases: A place for inter-organ and inter-kingdom crosstalks</article-title>. <source>Front. Cell Infect. Microbiol.</source> <volume>10</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcimb.2020.00009</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Feng</surname> <given-names>Q.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>W. D.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Y. D.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Gut microbiota: an integral moderator in health and disease</article-title>. <source>Front. Microbiol.</source> <volume>9</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fmicb.2018.00151</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fenn</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Abdel-Aziz</surname> <given-names>M. I.</given-names>
</name>
<name>
<surname>van Oort</surname> <given-names>P. M. P.</given-names>
</name>
<name>
<surname>Brinkman</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Ahmed</surname> <given-names>W. M.</given-names>
</name>
<name>
<surname>Felton</surname> <given-names>T.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>Composition and diversity analysis of the lung microbiome in patients with suspected ventilator-associated pneumonia</article-title>. <source>Crit. Care</source> <volume>26</volume>, <fpage>203</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s13054-022-04068-z</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Forsythe</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Kunze</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Bienenstock</surname> <given-names>J.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Moody microbes or fecal phrenology: what do we know about the microbiota-gut-brain axis</article-title>? <source>BMC Med.</source> <volume>14</volume>, <fpage>58</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12916-016-0604-8</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gasmi</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Tippairote</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Mujawdiya</surname> <given-names>P. K.</given-names>
</name>
<name>
<surname>Peana</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Menzel</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Dadar</surname> <given-names>M.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>The microbiota-mediated dietary and nutritional interventions for COVID-19</article-title>. <source>Clin. Immunol.</source> <volume>226</volume>, <elocation-id>108725</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.clim.2021.108725</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ghorbani</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Santhakumar</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>Q.</given-names>
</name>
<name>
<surname>Djiadeu</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Wolever</surname> <given-names>T. M.</given-names>
</name>
<name>
<surname>Palaniyar</surname> <given-names>N.</given-names>
</name>
<etal/>
</person-group>. (<year>2015</year>). <article-title>S hort-chain fatty acids affect cystic fibrosis airway inflammation and bacterial growth</article-title>. <source>Eur. Respir. J.</source> <volume>46</volume>, <fpage>1033</fpage>&#x2013;<lpage>1045</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1183/09031936.00143614</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goto</surname> <given-names>T.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Microbiota and lung cancer</article-title>. <source>Semin. Cancer Biol.</source> <volume>86</volume>, <fpage>1</fpage>&#x2013;<lpage>10</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.semcancer.2022.07.006</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grayson</surname> <given-names>M. H.</given-names>
</name>
<name>
<surname>Camarda</surname> <given-names>L. E.</given-names>
</name>
<name>
<surname>Hussain</surname> <given-names>S. A.</given-names>
</name>
<name>
<surname>Zemple</surname> <given-names>S. J.</given-names>
</name>
<name>
<surname>Hayward</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Lam</surname> <given-names>V.</given-names>
</name>
<etal/>
</person-group>. (<year>2018</year>). <article-title>Intestinal microbiota disruption reduces regulatory T cells and increases respiratory viral infection mortality through increased IFN&#x3b3; Production</article-title>. <source>Front. Immunol.</source> <volume>9</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2018.01587</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grice</surname> <given-names>E. A.</given-names>
</name>
<name>
<surname>Segre</surname> <given-names>J. A.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>The human microbiome: our second genome</article-title>. <source>Annu. Rev. Genomics Hum. Genet.</source> <volume>13</volume>, <fpage>151</fpage>&#x2013;<lpage>170</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1146/annurev-genom-090711-163814</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guler</surname> <given-names>A. T.</given-names>
</name>
<name>
<surname>Waaijer</surname> <given-names>C. J.</given-names>
</name>
<name>
<surname>Palmblad</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Scientific workflows for bibliometrics</article-title>. <source>Scientometrics</source> <volume>107</volume>, <fpage>385</fpage>&#x2013;<lpage>398</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s11192-016-1885-6</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Healy</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Munoz-Wolf</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Strydom</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Faherty</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Williams</surname> <given-names>N. C.</given-names>
</name>
<name>
<surname>Kenny</surname> <given-names>S.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Nutritional immunity: the impact of metals on lung immune cells and the airway microbiome during chronic respiratory disease</article-title>. <source>Respir. Res.</source> <volume>22</volume>, <fpage>133</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12931-021-01722-y</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Herbst</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Sichelstiel</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Sch&#xe4;r</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Yadava</surname> <given-names>K.</given-names>
</name>
<name>
<surname>B&#xfc;rki</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Cahenzli</surname> <given-names>J.</given-names>
</name>
<etal/>
</person-group>. (<year>2011</year>). <article-title>Dysregulation of allergic airway inflammation in the absence of microbial colonization</article-title>. <source>Am. J. Respir. Crit. Care Med.</source> <volume>184</volume>, <fpage>198</fpage>&#x2013;<lpage>205</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1164/rccm.201010-1574OC</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Shi</surname> <given-names>G.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Smoking and microbiome in oral, airway, gut and some systemic diseases</article-title>. <source>J. Transl. Med.</source> <volume>17</volume>, <fpage>225</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12967-019-1971-7</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jardou</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Lawson</surname> <given-names>R.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Supportive therapy during COVID-19: The proposed mechanism of short-chain fatty acids to prevent cytokine storm and multi-organ failure</article-title>. <source>Med. Hypotheses</source> <volume>154</volume>, <elocation-id>110661</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.mehy.2021.110661</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname> <given-names>S. K.</given-names>
</name>
<name>
<surname>Guevarra</surname> <given-names>R. B.</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>Y. T.</given-names>
</name>
<name>
<surname>Kwon</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Cho</surname> <given-names>J. H.</given-names>
</name>
<etal/>
</person-group>. (<year>2019</year>). <article-title>Role of probiotics in human gut microbiome-associated diseases</article-title>. <source>J. Microbiol. Biotechnol.</source> <volume>29</volume>, <fpage>1335</fpage>&#x2013;<lpage>1340</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.4014/jmb.1906.06064</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kleiner</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Hooper</surname> <given-names>L. V.</given-names>
</name>
<name>
<surname>Duerkop</surname> <given-names>B. A.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Evaluation of methods to purify virus-like particles for metagenomic sequencing of intestinal viromes</article-title>. <source>BMC Genomics</source> <volume>16</volume>, <elocation-id>7</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12864-014-1207-4</pub-id>
</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname> <given-names>J. T.</given-names>
</name>
<name>
<surname>Kim</surname> <given-names>C. M.</given-names>
</name>
<name>
<surname>Ramakrishnan</surname> <given-names>V.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Microbiome and disease in the upper airway</article-title>. <source>Curr. Opin. Allergy Clin. Immunol.</source> <volume>19</volume>, <fpage>1</fpage>&#x2013;<lpage>6</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/ACI.0000000000000495</pub-id>
</citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ley</surname> <given-names>R. E.</given-names>
</name>
<name>
<surname>Peterson</surname> <given-names>D. A.</given-names>
</name>
<name>
<surname>Gordon</surname> <given-names>J. I.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Ecological and evolutionary forces shaping microbial diversity in the human intestine</article-title>. <source>Cell</source> <volume>124</volume>, <fpage>837</fpage>&#x2013;<lpage>848</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.cell.2006.02.017</pub-id>
</citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>H. Y.</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>D. D.</given-names>
</name>
<name>
<surname>Gan</surname> <given-names>R. Y.</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>S. Y.</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>C. N.</given-names>
</name>
<name>
<surname>Shang</surname> <given-names>A.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Effects and mechanisms of probiotics, prebiotics, synbiotics, and postbiotics on metabolic diseases targeting gut microbiota: A narrative review</article-title>. <source>Nutrients</source> <volume>13</volume>, <elocation-id>3211</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/nu13093211</pub-id>
</citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liang</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>W.</given-names>
</name>
<name>
<surname>He</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Kahaer</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>R.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>Diagnostic model for predicting hyperuricemia based on alterations of the gut microbiome in individuals with different serum uric acid levels</article-title>. <source>Front. Endocrinol. (Lausanne)</source> <volume>13</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fendo.2022.925119</pub-id>
</citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Licciardi</surname> <given-names>P. V.</given-names>
</name>
<name>
<surname>Toh</surname> <given-names>Z. Q.</given-names>
</name>
<name>
<surname>Dunne</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Wong</surname> <given-names>S. S.</given-names>
</name>
<name>
<surname>Mulholland</surname> <given-names>E. K.</given-names>
</name>
<name>
<surname>Tang</surname> <given-names>M.</given-names>
</name>
<etal/>
</person-group>. (<year>2012</year>). <article-title>Protecting against pneumococcal disease: critical interactions between probiotics and the airway microbiome</article-title>. <source>PloS Pathog.</source> <volume>8</volume>, <elocation-id>e1002652</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.ppat.1002652</pub-id>
</citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>X.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Sputum microbiota as a potential diagnostic marker for multidrug-resistant tuberculosis</article-title>. <source>Int. J. Med. Sci.</source> <volume>18</volume>, <fpage>1935</fpage>&#x2013;<lpage>1945</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.7150/ijms.53492</pub-id>
</citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Yi</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Meng</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>X.</given-names>
</name>
<etal/>
</person-group>. (<year>2023</year>). <article-title>The airway microbiome mediates the interaction between environmental exposure and respiratory health in humans</article-title>. <source>Nat. Med.</source> <volume>29</volume>, <fpage>1750</fpage>&#x2013;<lpage>1759</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41591-023-02424-2</pub-id>
</citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname> <given-names>T. F. D.</given-names>
</name>
<name>
<surname>Philippou</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Kolokotroni</surname> <given-names>O.</given-names>
</name>
<name>
<surname>Siakallis</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Rahima</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Constantinou</surname> <given-names>C.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Gut and airway microbiota and their role in COVID-19 infection and pathogenesis: a scoping review</article-title>. <source>Infection</source> <volume>50</volume>, <fpage>815</fpage>&#x2013;<lpage>847</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s15010-021-01715-5</pub-id>
</citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ma</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Su</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>H.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Global research trends on prostate diseases and erectile dysfunction: A bibliometric and visualized study</article-title>. <source>Front. Oncol.</source> <volume>10</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fonc.2020.627891</pub-id>
</citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ma</surname> <given-names>P. J.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>M. M.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>Y.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Gut microbiota: A new insight into lung diseases</article-title>. <source>BioMed. Pharmacother.</source> <volume>155</volume>, <elocation-id>113810</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.biopha.2022.113810</pub-id>
</citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mac Aog&#xe1;in</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Lau</surname> <given-names>K. J. X.</given-names>
</name>
<name>
<surname>Cai</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Kumar Narayana</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Purbojati</surname> <given-names>R. W.</given-names>
</name>
<name>
<surname>Drautz-Moses</surname> <given-names>D. I.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>Metagenomics reveals a core macrolide resistome related to microbiota in chronic respiratory disease</article-title>. <source>Am. J. Respir. Crit. Care Med.</source> <volume>202</volume>, <fpage>433</fpage>&#x2013;<lpage>447</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1164/rccm.201911-2202OC</pub-id>
</citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martin-Loeches</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Dickson</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Torres</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Hanberger</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Lipman</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Antonelli</surname> <given-names>M. d.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>The importance of airway and lung microbiome in the critically ill</article-title>. <source>Crit. Care</source> <volume>24</volume>, <fpage>537</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s13054-020-03219-4</pub-id>
</citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Matsuzaki</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Yokokura</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Azuma</surname> <given-names>I.</given-names>
</name>
</person-group> (<year>1985</year>). <article-title>Anti-tumour activity of Lactobacillus casei on Lewis lung carcinoma and line-10 hepatoma in syngeneic mice and Guinea pigs</article-title>. <source>Cancer Immunol. Immunother.</source> <volume>20</volume>, <fpage>18</fpage>&#x2013;<lpage>22</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/BF00199768</pub-id>
</citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>McGinniss</surname> <given-names>J. E.</given-names>
</name>
<name>
<surname>Collman</surname> <given-names>R. G.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>The upper airway microbiome and lung injury in COVID-19</article-title>. <source>Am. J. Respir. Crit. Care Med.</source> <volume>204</volume>, <fpage>1353</fpage>&#x2013;<lpage>1355</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1164/rccm.202109-2226ED</pub-id>
</citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mirmonsef</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Zariffard</surname> <given-names>M. R.</given-names>
</name>
<name>
<surname>Gilbert</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Makinde</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Landay</surname> <given-names>A. L.</given-names>
</name>
<name>
<surname>Spear</surname> <given-names>G. T.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Short-chain fatty acids induce pro-inflammatory cytokine production alone and in combination with toll-like receptor ligands</article-title>. <source>Am. J. Reprod. Immunol.</source> <volume>67</volume>, <fpage>391</fpage>&#x2013;<lpage>400</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1600-0897.2011.01089.x</pub-id>
</citation>
</ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>O&#x2019;Hara</surname> <given-names>A. M.</given-names>
</name>
<name>
<surname>Shanahan</surname> <given-names>F.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>The gut flora as a forgotten organ</article-title>. <source>EMBO Rep.</source> <volume>7</volume>, <fpage>688</fpage>&#x2013;<lpage>693</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/sj.embor.7400731</pub-id>
</citation>
</ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pan</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Yan</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Cui</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Hua</surname> <given-names>W.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Examining the usage, citation, and diffusion patterns of bibliometric mapping software: A comparative study of three tools</article-title>. <source>J. Informetrics</source> <volume>12</volume>, <fpage>481</fpage>&#x2013;<lpage>493</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.joi.2018.03.005</pub-id>
</citation>
</ref>
<ref id="B52">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pattaroni</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Watzenboeck</surname> <given-names>M. L.</given-names>
</name>
<name>
<surname>Schneidegger</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Kieser</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Wong</surname> <given-names>N. C.</given-names>
</name>
<name>
<surname>Bernasconi</surname> <given-names>E.</given-names>
</name>
<etal/>
</person-group>. (<year>2018</year>). <article-title>Early-life formation of the microbial and immunological environment of the human airways</article-title>. <source>Cell Host Microbe</source> <volume>24</volume>, <fpage>857</fpage>&#x2013;<lpage>865.e4</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.chom.2018.10.019</pub-id>
</citation>
</ref>
<ref id="B53">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ragan</surname> <given-names>M. V.</given-names>
</name>
<name>
<surname>Wala</surname> <given-names>S. J.</given-names>
</name>
<name>
<surname>Goodman</surname> <given-names>S. D.</given-names>
</name>
<name>
<surname>Bailey</surname> <given-names>M. T.</given-names>
</name>
<name>
<surname>Besner</surname> <given-names>G. E.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Next-generation probiotic therapy to protect the intestines from injury</article-title>. <source>Front. Cell Infect. Microbiol.</source> <volume>12</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fcimb.2022.863949</pub-id>
</citation>
</ref>
<ref id="B54">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rastogi</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Mohanty</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Sharma</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Tripathi</surname> <given-names>P.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Possible role of gut microbes and host&#x2019;s immune response in gut-lung homeostasis</article-title>. <source>Front. Immunol.</source> <volume>13</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2022.954339</pub-id>
</citation>
</ref>
<ref id="B55">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reid</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Abrahamsson</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Bailey</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Bindels</surname> <given-names>L. B.</given-names>
</name>
<name>
<surname>Bubnov</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Ganguli</surname> <given-names>K.</given-names>
</name>
<etal/>
</person-group>. (<year>2017</year>). <article-title>How do probiotics and prebiotics function at distant sites</article-title>? <source>Benef Microbes</source> <volume>8</volume>, <fpage>521</fpage>&#x2013;<lpage>533</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3920/BM2016.0222</pub-id>
</citation>
</ref>
<ref id="B56">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reyes</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Semenkovich</surname> <given-names>N. P.</given-names>
</name>
<name>
<surname>Whiteson</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Rohwer</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Gordon</surname> <given-names>J. I.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Going viral: next-generation sequencing applied to phage populations in the human gut</article-title>. <source>Nat. Rev. Microbiol.</source> <volume>10</volume>, <fpage>607</fpage>&#x2013;<lpage>617</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nrmicro2853</pub-id>
</citation>
</ref>
<ref id="B57">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rutting</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Xenaki</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Malouf</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Horvat</surname> <given-names>J. C.</given-names>
</name>
<name>
<surname>Wood</surname> <given-names>L. G.</given-names>
</name>
<name>
<surname>Hansbro</surname> <given-names>P. M.</given-names>
</name>
<etal/>
</person-group>. (<year>2019</year>). <article-title>Short-chain fatty acids increase TNF&#x3b1;-induced inflammation in primary human lung mesenchymal cells through the activation of p38 MAPK</article-title>. <source>Am. J. Physiol. Lung Cell Mol. Physiol.</source> <volume>316</volume>, <fpage>L157</fpage>&#x2013;<lpage>L174</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1152/ajplung.00306.2018</pub-id>
</citation>
</ref>
<ref id="B58">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Samuelson</surname> <given-names>D. R.</given-names>
</name>
<name>
<surname>Welsh</surname> <given-names>D. A.</given-names>
</name>
<name>
<surname>Shellito</surname> <given-names>J. E.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Regulation of lung immunity and host defense by the intestinal microbiota</article-title>. <source>Front. Microbiol.</source> <volume>6</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fmicb.2015.01085</pub-id>
</citation>
</ref>
<ref id="B59">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sequeira</surname> <given-names>R. P.</given-names>
</name>
<name>
<surname>McDonald</surname> <given-names>J. A. K.</given-names>
</name>
<name>
<surname>Marchesi</surname> <given-names>J. R.</given-names>
</name>
<name>
<surname>Clarke</surname> <given-names>T. B.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Commensal Bacteroidetes protect against Klebsiella pneumoniae colonization and transmission through IL-36 signalling</article-title>. <source>Nat. Microbiol.</source> <volume>5</volume>, <fpage>304</fpage>&#x2013;<lpage>313</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41564-019-0640-1</pub-id>
</citation>
</ref>
<ref id="B60">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shah</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Bunyavanich</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>The airway microbiome and pediatric asthma</article-title>. <source>Curr. Opin. Pediatr.</source> <volume>33</volume>, <fpage>639</fpage>&#x2013;<lpage>647</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1097/MOP.0000000000001054</pub-id>
</citation>
</ref>
<ref id="B61">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sherrard</surname> <given-names>L. J.</given-names>
</name>
<name>
<surname>Tunney</surname> <given-names>M. M.</given-names>
</name>
<name>
<surname>Elborn</surname> <given-names>J. S.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Antimicrobial resistance in the respiratory microbiota of people with cystic fibrosis</article-title>. <source>Lancet</source> <volume>384</volume>, <fpage>703</fpage>&#x2013;<lpage>713</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0140-6736(14)61137-5</pub-id>
</citation>
</ref>
<ref id="B62">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smith</surname> <given-names>P. M.</given-names>
</name>
<name>
<surname>Howitt</surname> <given-names>M. R.</given-names>
</name>
<name>
<surname>Panikov</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Michaud</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Gallini</surname> <given-names>C. A.</given-names>
</name>
<name>
<surname>Bohlooly</surname> <given-names>Y. M.</given-names>
</name>
<etal/>
</person-group>. (<year>2013</year>). <article-title>The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis</article-title>. <source>Science</source> <volume>341</volume>, <fpage>569</fpage>&#x2013;<lpage>573</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1126/science.1241165</pub-id>
</citation>
</ref>
<ref id="B63">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Steed</surname> <given-names>A. L.</given-names>
</name>
<name>
<surname>Christophi</surname> <given-names>G. P.</given-names>
</name>
<name>
<surname>Kaiko</surname> <given-names>G. E.</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Goodwin</surname> <given-names>V. M.</given-names>
</name>
<name>
<surname>Jain</surname> <given-names>U.</given-names>
</name>
<etal/>
</person-group>. (<year>2017</year>). <article-title>The microbial metabolite desaminotyrosine protects from influenza through type I interferon</article-title>. <source>Science</source> <volume>357</volume>, <fpage>498</fpage>&#x2013;<lpage>502</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1126/science.aam5336</pub-id>
</citation>
</ref>
<ref id="B64">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Subramaniam</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Hillberry</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Feng</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Fletcher</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Neuenschwander</surname> <given-names>P.</given-names>
</name>
<etal/>
</person-group>. (<year>2015</year>). <article-title>Delivery of GM-CSF to protect against influenza pneumonia</article-title>. <source>PloS One</source> <volume>10</volume>, <elocation-id>e0124593</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0124593</pub-id>
</citation>
</ref>
<ref id="B65">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Dong</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Dong</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>Q.</given-names>
</name>
<name>
<surname>Fang</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>C.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>Drug repositioning: A bibliometric analysis</article-title>. <source>Front. Pharmacol.</source> <volume>13</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fphar.2022.974849</pub-id>
</citation>
</ref>
<ref id="B66">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Synnestvedt</surname> <given-names>M. B.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Holmes</surname> <given-names>J. H.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>CiteSpace II: visualization and knowledge discovery in bibliographic databases</article-title>. <source>AMIA Annu. Symp Proc.</source> <volume>2005</volume>, <fpage>724</fpage>&#x2013;<lpage>728</lpage>.</citation>
</ref>
<ref id="B67">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tan</surname> <given-names>J.</given-names>
</name>
<name>
<surname>McKenzie</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Potamitis</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Thorburn</surname> <given-names>A. N.</given-names>
</name>
<name>
<surname>Mackay</surname> <given-names>C. R.</given-names>
</name>
<name>
<surname>Macia</surname> <given-names>L.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>The role of short-chain fatty acids in health and disease</article-title>. <source>Adv. Immunol.</source> <volume>121</volume>, <fpage>91</fpage>&#x2013;<lpage>119</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/B978-0-12-800100-4.00003-9</pub-id>
</citation>
</ref>
<ref id="B68">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tang</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Zeng</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Gong</surname> <given-names>F.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Effect of gut microbiota on LPS-induced acute lung injury by regulating the TLR4/NF-kB signaling pathway</article-title>. <source>Int. Immunopharmacol</source> <volume>91</volume>, <elocation-id>107272</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.intimp.2020.107272</pub-id>
</citation>
</ref>
<ref id="B69">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tiew</surname> <given-names>P. Y.</given-names>
</name>
<name>
<surname>Jaggi</surname> <given-names>T. K.</given-names>
</name>
<name>
<surname>Chan</surname> <given-names>L. L. Y.</given-names>
</name>
<name>
<surname>Chotirmall</surname> <given-names>S. H.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>The airway microbiome in COPD, bronchiectasis and bronchiectasis-COPD overlap</article-title>. <source>Clin. Respir. J.</source> <volume>15</volume>, <fpage>123</fpage>&#x2013;<lpage>133</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/crj.13294</pub-id>
</citation>
</ref>
<ref id="B70">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Trompette</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Gollwitzer</surname> <given-names>E. S.</given-names>
</name>
<name>
<surname>Yadava</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Sichelstiel</surname> <given-names>A. K.</given-names>
</name>
<name>
<surname>Sprenger</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Ngom-Bru</surname> <given-names>C.</given-names>
</name>
<etal/>
</person-group>. (<year>2014</year>). <article-title>Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis</article-title>. <source>Nat. Med.</source> <volume>20</volume>, <fpage>159</fpage>&#x2013;<lpage>166</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/nm.3444</pub-id>
</citation>
</ref>
<ref id="B71">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tsay</surname> <given-names>J. J.</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>B. G.</given-names>
</name>
<name>
<surname>Badri</surname> <given-names>M. H.</given-names>
</name>
<name>
<surname>Clemente</surname> <given-names>J. C.</given-names>
</name>
<name>
<surname>Shen</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Meyn</surname> <given-names>P.</given-names>
</name>
<etal/>
</person-group>. (<year>2018</year>). <article-title>Airway microbiota is associated with upregulation of the PI3K pathway in lung cancer</article-title>. <source>Am. J. Respir. Crit. Care Med.</source> <volume>198</volume>, <fpage>1188</fpage>&#x2013;<lpage>1198</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1164/rccm.201710-2118OC</pub-id>
</citation>
</ref>
<ref id="B72">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tsay</surname> <given-names>J. J.</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>B. G.</given-names>
</name>
<name>
<surname>Sulaiman</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Gershner</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Schluger</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>Y.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Lower airway dysbiosis affects lung cancer progression</article-title>. <source>Cancer Discovery</source> <volume>11</volume>, <fpage>293</fpage>&#x2013;<lpage>307</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1158/2159-8290.CD-20-0263</pub-id>
</citation>
</ref>
<ref id="B73">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>van Eck</surname> <given-names>N. J.</given-names>
</name>
<name>
<surname>Waltman</surname> <given-names>L.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Software survey: VOSviewer, a computer program for bibliometric mapping</article-title>. <source>Scientometrics</source> <volume>84</volume>, <fpage>523</fpage>&#x2013;<lpage>538</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s11192-009-0146-3</pub-id>
</citation>
</ref>
<ref id="B74">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ver Heul</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Planer</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Kau</surname> <given-names>A. L.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>The human microbiota and asthma</article-title>. <source>Clin. Rev. Allergy Immunol.</source> <volume>57</volume>, <fpage>350</fpage>&#x2013;<lpage>363</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s12016-018-8719-7</pub-id>
</citation>
</ref>
<ref id="B75">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Tian</surname> <given-names>Z.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Role of microbiota on lung homeostasis and diseases</article-title>. <source>Sci. China Life Sci.</source> <volume>60</volume>, <fpage>1407</fpage>&#x2013;<lpage>1415</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s11427-017-9151-1</pub-id>
</citation>
</ref>
<ref id="B76">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Maniruzzaman</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>A global bibliometric and visualized analysis of bacteria-mediated cancer therapy</article-title>. <source>Drug Discovery Today</source> <volume>27</volume>, <fpage>103297</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.drudis.2022.05.023</pub-id>
</citation>
</ref>
<ref id="B77">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Ren</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Zhu</surname> <given-names>W.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>A.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Potential associations between microbiome and COVID-19</article-title>. <source>Front. Med. (Lausanne)</source> <volume>22</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fmed.2021.785496</pub-id>
</citation>
</ref>
<ref id="B78">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>X.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Probiotics regulate gut microbiota: an effective method to improve immunity</article-title>. <source>Molecules</source> <volume>26</volume>, <elocation-id>6076</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/molecules26196076</pub-id>
</citation>
</ref>
<ref id="B79">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wypych</surname> <given-names>T. P.</given-names>
</name>
<name>
<surname>Pattaroni</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Perdijk</surname> <given-names>O.</given-names>
</name>
<name>
<surname>Yap</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Trompette</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Anderson</surname> <given-names>D.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Microbial metabolism of L-tyrosine protects against allergic airway inflammation</article-title>. <source>Nat. Immunol.</source> <volume>22</volume>, <fpage>279</fpage>&#x2013;<lpage>286</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41590-020-00856-3</pub-id>
</citation>
</ref>
<ref id="B80">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yagi</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Huffnagle</surname> <given-names>G. B.</given-names>
</name>
<name>
<surname>Lukacs</surname> <given-names>N. W.</given-names>
</name>
<name>
<surname>Asai</surname> <given-names>N.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>The lung microbiome during health and disease</article-title>. <source>Int. J. Mol. Sci.</source> <volume>22</volume>, <elocation-id>10872</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijms221910872</pub-id>
</citation>
</ref>
<ref id="B81">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yan</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Yi</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Wei</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Ecklu-Mensah</surname> <given-names>G.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>Multi-omics analyses of airway host-microbe interactions in chronic obstructive pulmonary disease identify potential therapeutic interventions</article-title>. <source>Nat. Microbiol.</source> <volume>7</volume>, <fpage>1361</fpage>&#x2013;<lpage>1375</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41564-022-01196-8</pub-id>
</citation>
</ref>
<ref id="B82">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yan</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Polk</surname> <given-names>D. B.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Probiotics and probiotic-derived functional factors-mechanistic insights into applications for intestinal homeostasis</article-title>. <source>Front. Immunol.</source> <volume>11</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2020.01428</pub-id>
</citation>
</ref>
<ref id="B83">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yuan</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Guo</surname> <given-names>X.</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Zuo</surname> <given-names>X.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>Airway microbiome and serum metabolomics analysis identify differential candidate biomarkers in allergic rhinitis</article-title>. <source>Front. Immunol.</source> <volume>12</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2021.771136</pub-id>
</citation>
</ref>
<ref id="B84">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zheng</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>D.</given-names>
</name>
<etal/>
</person-group>. (<year>2023</year>). <article-title>Gut microbiome as a biomarker for predicting early recurrence of HBV-related hepatocellular carcinoma</article-title>. <source>Cancer Sci.</source> <volume>114</volume>, <fpage>4717</fpage>&#x2013;<lpage>4731</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/cas.15983</pub-id>
</citation>
</ref>
<ref id="B85">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zheng</surname> <given-names>Y. Y.</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>T. T.</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>Z. Q.</given-names>
</name>
<name>
<surname>Li</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Guo</surname> <given-names>Q. Q.</given-names>
</name>
<name>
<surname>Ma</surname> <given-names>Y. Y.</given-names>
</name>
<etal/>
</person-group>. (<year>2020</year>). <article-title>Gut microbiome-based diagnostic model to predict coronary artery disease</article-title>. <source>J. Agric. Food Chem.</source> <volume>68</volume>, <fpage>3548</fpage>&#x2013;<lpage>3557</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1021/acs.jafc.0c00225</pub-id>
</citation>
</ref>
<ref id="B86">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Lei</surname> <given-names>Y.</given-names>
</name>
<name>
<surname>Tang</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Yang</surname> <given-names>M.</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>L.</given-names>
</name>
<etal/>
</person-group>. (<year>2021</year>). <article-title>Gut microbiota: the emerging link to lung homeostasis and disease</article-title>. <source>J. Bacteriol</source> <volume>203</volume>, <fpage>e00454</fpage>&#x2013;<lpage>e00420</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/JB.00454-20</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>